<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Pers Med</journal-id>
<journal-id journal-id-type="iso-abbrev">J Pers Med</journal-id>
<journal-id journal-id-type="publisher-id">jpm</journal-id>
<journal-title-group>
<journal-title>Journal of Personalized Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2075-4426</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32041088</article-id>
<article-id pub-id-type="pmc">7151621</article-id>
<article-id pub-id-type="doi">10.3390/jpm10010008</article-id>
<article-id pub-id-type="publisher-id">jpm-10-00008</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Argentati</surname>
<given-names>Chiara</given-names>
</name>
<xref ref-type="aff" rid="af1-jpm-10-00008">1</xref>
<xref ref-type="author-notes" rid="fn1-jpm-10-00008">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tortorella</surname>
<given-names>Ilaria</given-names>
</name>
<xref ref-type="aff" rid="af1-jpm-10-00008">1</xref>
<xref ref-type="author-notes" rid="fn1-jpm-10-00008">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bazzucchi</surname>
<given-names>Martina</given-names>
</name>
<xref ref-type="aff" rid="af1-jpm-10-00008">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morena</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="af1-jpm-10-00008">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martino</surname>
<given-names>Sabata</given-names>
</name>
<xref ref-type="aff" rid="af1-jpm-10-00008">1</xref>
<xref ref-type="aff" rid="af2-jpm-10-00008">2</xref>
<xref ref-type="corresp" rid="c1-jpm-10-00008">*</xref>
</contrib>
</contrib-group>
<aff id="af1-jpm-10-00008"><label>1</label>Department of Chemistry, Biology and Biotechnologies, University of Perugia, Via del Giochetto, 06126 Perugia, Italy; <email>chiara.argentati89@gmail.com</email> (C.A.); <email>tortorella.i@hotmail.it</email> (I.T.); <email>martina.bazzucchi89@gmail.com</email> (M.B.); <email>francesco.morena@unipg.it</email> (F.M.)</aff>
<aff id="af2-jpm-10-00008"><label>2</label>CEMIN, Center of Excellence on Nanostructured Innovative Materials, Via del Giochetto, 06126 Perugia, Italy</aff>
<author-notes>
<corresp id="c1-jpm-10-00008"><label>*</label>Correspondence: <email>sabata.martino@unipg.it</email>; Tel.: +39-075-585-7442</corresp>
<fn id="fn1-jpm-10-00008">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>3</month>
<year>2020</year>
</pub-date>
<volume>10</volume>
<issue>1</issue>
<elocation-id>8</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>12</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Ex vivo cell/tissue-based models are an essential step in the workflow of pathophysiology studies, assay development, disease modeling, drug discovery, and development of personalized therapeutic strategies. For these purposes, both scientific and pharmaceutical research have adopted ex vivo stem cell models because of their better predictive power. As matter of a fact, the advancing in isolation and in vitro expansion protocols for culturing autologous human stem cells, and the standardization of methods for generating patient-derived induced pluripotent stem cells has made feasible to generate and investigate human cellular disease models with even greater speed and efficiency. Furthermore, the potential of stem cells on generating more complex systems, such as scaffold-cell models, organoids, or organ-on-a-chip, allowed to overcome the limitations of the two-dimensional culture systems as well as to better mimic tissues structures and functions. Finally, the advent of genome-editing/gene therapy technologies had a great impact on the generation of more proficient stem cell-disease models and on establishing an effective therapeutic treatment. In this review, we discuss important breakthroughs of stem cell-based models highlighting current directions, advantages, and limitations and point out the need to combine experimental biology with computational tools able to describe complex biological systems and deliver results or predictions in the context of personalized medicine.</p>
</abstract>
<kwd-group>
<kwd>organoids</kwd>
<kwd>organ-on-a-chip</kwd>
<kwd>iPSCs</kwd>
<kwd>gene therapy</kwd>
<kwd>genome editing</kwd>
<kwd>tissue engineering</kwd>
<kwd>computational cell modeling</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-jpm-10-00008" sec-type="intro">
<title>1. Introduction</title>
<p>Over the past decades, much of our understanding of human physiology and pathologies has been derived from studies on animal models. However, during the years, emerging limitations have raised doubts about the reliability of this investigational approach [<xref ref-type="bibr" rid="B1-jpm-10-00008">1</xref>]. The main criticisms about the actual predictive value of animal models are related to (i) their limits on fully recapitulating the human physiology/pathologies (e.g., different pharmacokinetics and toxicokinetic; presence of alternative pathways that may interfere with the progression of a given disease; different immune-response), (ii) their maintenance costs, and (iii) the ethical issues associated with their use [<xref ref-type="bibr" rid="B2-jpm-10-00008">2</xref>,<xref ref-type="bibr" rid="B3-jpm-10-00008">3</xref>,<xref ref-type="bibr" rid="B4-jpm-10-00008">4</xref>]. Thus, even if animal models, especially mammals, are still an essential tool before a novel therapeutic strategy enters clinical trials, their use is severely restricted [<xref ref-type="bibr" rid="B5-jpm-10-00008">5</xref>]. In order to overcome these limitations, scientists have focused on finding alternative approaches and tools that could recapitulate the homeostasis of cells/tissues as well as pathological alterations. Therefore, in vitro cell/tissue models today became a very promising tool for investigating human development, physiology and disease pathogenesis.</p>
<p>Here, we review the progress made in establishing the most proficient cell/tissue modeling, from basic cell culture systems to more innovative organoid platforms.</p>
</sec>
<sec id="sec2-jpm-10-00008">
<title>2. Cell Modeling Overview: From Basic 2D-Cultures to 3D-Innovative Systems</title>
<p>Since their establishment, cell cultures have been proven to be the first and most powerful tool for the in vitro investigation of cell biology, from basic research to more complex translational approaches [<xref ref-type="bibr" rid="B6-jpm-10-00008">6</xref>]. Classical two-dimensional (2D)-cultures usually consist of a unique type of cells (primary or continuous cultures) that grow in tissue culture polystyrene as adherent monolayers or in floating suspension, both in culture media that provide essential nutrients and growth factors. 2D-strategies are widely used to obtain a large number of cells, thus allowing the in vitro study of molecular mechanisms and development of metabolic assays [<xref ref-type="bibr" rid="B7-jpm-10-00008">7</xref>,<xref ref-type="bibr" rid="B8-jpm-10-00008">8</xref>,<xref ref-type="bibr" rid="B9-jpm-10-00008">9</xref>]. However, due to their inability to recreate the in vivo complexity of the biological environment, they are not suitable for accurate disease modeling. These limitations have been overcome by the development of three-dimensional (3D)-cell cultures systems [<xref ref-type="bibr" rid="B10-jpm-10-00008">10</xref>]. The rationale design of 3D-cell cultures is to harvest cells in microstructures that resemble tissues or organs shape and organization, thus allowing better cell-to-cell/cell-environment contacts and signaling crosstalk [<xref ref-type="bibr" rid="B11-jpm-10-00008">11</xref>,<xref ref-type="bibr" rid="B12-jpm-10-00008">12</xref>,<xref ref-type="bibr" rid="B13-jpm-10-00008">13</xref>,<xref ref-type="bibr" rid="B14-jpm-10-00008">14</xref>,<xref ref-type="bibr" rid="B15-jpm-10-00008">15</xref>], essential events for tissues correct development and functioning [<xref ref-type="bibr" rid="B14-jpm-10-00008">14</xref>,<xref ref-type="bibr" rid="B15-jpm-10-00008">15</xref>]. The 3D-cell culture strategy is articulated in many different methods and techniques that can be grouped in scaffold-based or non-scaffold based platforms, each with particular advantages and disadvantages that make them useful for different applications [<xref ref-type="bibr" rid="B10-jpm-10-00008">10</xref>,<xref ref-type="bibr" rid="B16-jpm-10-00008">16</xref>,<xref ref-type="bibr" rid="B17-jpm-10-00008">17</xref>,<xref ref-type="bibr" rid="B18-jpm-10-00008">18</xref>,<xref ref-type="bibr" rid="B19-jpm-10-00008">19</xref>]. 3D-cell culture strategies are supported by the in silico modeling of multicellular systems that requires sophisticated techniques that go beyond the standard model formalisms in systems biology and allows complicated geometrical constructions [<xref ref-type="bibr" rid="B20-jpm-10-00008">20</xref>,<xref ref-type="bibr" rid="B21-jpm-10-00008">21</xref>]. In this regard, many computational tools allow predicting the more proficient cell model. These methods enable formulating both compartmental and spatial models with either 2D- or 3D-geometries, theoretically- or experimentally-derived. Several modeler environments have been developed in order to simulate and incorporate cell-based models, to describe the interactions and dynamics of cell-bound variables and to define molecular species in reaction–diffusion systems [<xref ref-type="bibr" rid="B22-jpm-10-00008">22</xref>,<xref ref-type="bibr" rid="B23-jpm-10-00008">23</xref>,<xref ref-type="bibr" rid="B24-jpm-10-00008">24</xref>,<xref ref-type="bibr" rid="B25-jpm-10-00008">25</xref>,<xref ref-type="bibr" rid="B26-jpm-10-00008">26</xref>,<xref ref-type="bibr" rid="B27-jpm-10-00008">27</xref>,<xref ref-type="bibr" rid="B28-jpm-10-00008">28</xref>,<xref ref-type="bibr" rid="B29-jpm-10-00008">29</xref>,<xref ref-type="bibr" rid="B30-jpm-10-00008">30</xref>,<xref ref-type="bibr" rid="B31-jpm-10-00008">31</xref>,<xref ref-type="bibr" rid="B32-jpm-10-00008">32</xref>]. These computational tools allow simulating a wide range of cellular phenomena in space and time, both deterministically and stochastically (<xref ref-type="table" rid="jpm-10-00008-t001">Table 1</xref>).</p>
<p>All of the above-mentioned techniques have been developed to respond to the compelling need to find better preclinical models for the study and modeling of disease pathogenesis.</p>
</sec>
<sec id="sec3-jpm-10-00008">
<title>3. Ex Vivo Stem Cell-Based Modeling Systems</title>
<p>Currently, stem cells (SCs) disease models represent the most powerful tool for having a better understanding of human disease pathogenesis and for developing new therapies [<xref ref-type="bibr" rid="B33-jpm-10-00008">33</xref>]. As a matter of fact, the translation of stem cells intrinsic properties (i.e., self-renewal and pluri/multipotency) into an in vitro system allows the generation of selected cell lineages involved in the pathogenesis of a specific disease, along with promoting drug discovery, molecular screening, and transplantation therapies [<xref ref-type="bibr" rid="B33-jpm-10-00008">33</xref>]. The first discoveries about SCs date back almost forty years when Evans and Kaufman isolated pluripotent cells from mouse embryos and established in vitro cultures of embryonic stem cells [<xref ref-type="bibr" rid="B34-jpm-10-00008">34</xref>]. Since then, much research has been done in SCs field and today new stem cell-based disease models offer the possibility of personalizing the model according to the patient, observing a phenotype and then obtaining stem cells with the genotype of the donor subject, allowing to study also genetically complex disorders [<xref ref-type="bibr" rid="B35-jpm-10-00008">35</xref>,<xref ref-type="bibr" rid="B36-jpm-10-00008">36</xref>].</p>
<p>Among stem cell types, the most used for disease modeling purposes are adult stem cells (multipotent) [<xref ref-type="bibr" rid="B37-jpm-10-00008">37</xref>] and induced pluripotent stem cells (iPSCs), because they permit the establishment of more advanced ex vivo models through: (i) Generation of committed/differentiated cell types involved in the disease; (ii) combination with biomaterials to generate a bio-hybrid system for tissue engineering applications; (iii) generation of organoids; and (iv) generation of organs-on-a-chip systems (<xref ref-type="fig" rid="jpm-10-00008-f001">Figure 1</xref>). Furthermore, the genome editing and gene therapy biotechnologies can be auxiliary tools to achieve the generation of more proficient stem cells disease models (<xref ref-type="fig" rid="jpm-10-00008-f001">Figure 1</xref>).</p>
<p>The advent of iPSCs opened a wide range of new stem cell applications. It is well-known that iPSCs can be derived from differentiated somatic cells, such as fibroblasts, by introducing defined transcriptional factors according to the Yamanaka and Takahashi protocol [<xref ref-type="bibr" rid="B38-jpm-10-00008">38</xref>] and, like other pluripotent stem cells, have wide differentiation ability, giving rise to all cell derivatives of the three germ layers. As a matter of fact, the in vitro generation of iPSCs from somatic cells has made feasible the molecular study of different types of diseases, such as neurodegenerative diseases and cardiac diseases (see the list on <xref ref-type="table" rid="jpm-10-00008-t002">Table 2</xref>), for which is difficult to obtain a tissue biopsy and autologous stem cells. For example, Israel et al. generated iPSCs from Sporadic Alzheimer’s disease patients, demonstrating that they have high levels of Amyloid-β and Tau protein hyperphosphorylation and that they represent a suitable model to study the correlation of phosphorylation of Tau, activation of GSK-3β and the processing of APP by the activity of β-secretase [<xref ref-type="bibr" rid="B39-jpm-10-00008">39</xref>]. iPSCs have been also used to study the neuronal differentiation and the neurodegeneration in a familial form of amyotrophic lateral sclerosis [<xref ref-type="bibr" rid="B40-jpm-10-00008">40</xref>] as well as to study the effect of α-synuclein gene triplication in Parkinson’s disease patients together with the identification of therapeutic compounds against α-synuclein accumulation [<xref ref-type="bibr" rid="B41-jpm-10-00008">41</xref>].</p>
<p>Nevertheless, when somatic cells are reprogrammed to generate iPSCs, they acquire a series of new intrinsic properties that might generate hurdles in their applications. In fact, in addition to teratoma formation, karyotypic abnormalities and immature phenotype, they are characterized by unpredictable genetic background variations, thus making less reliable the corresponding disease model [<xref ref-type="bibr" rid="B42-jpm-10-00008">42</xref>]. In this regard, genome editing tools enable creating isogenic controls iPSCs that differ from the original counterpart only on the gene/s responsible for the disease [<xref ref-type="bibr" rid="B43-jpm-10-00008">43</xref>,<xref ref-type="bibr" rid="B44-jpm-10-00008">44</xref>]. Despite these limitations, iPSCs have shown to be very promising for recapitulating complex genetically disorders especially when combined with gene editing techniques [<xref ref-type="bibr" rid="B33-jpm-10-00008">33</xref>,<xref ref-type="bibr" rid="B45-jpm-10-00008">45</xref>,<xref ref-type="bibr" rid="B46-jpm-10-00008">46</xref>].</p>
<table-wrap id="jpm-10-00008-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">jpm-10-00008-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>List of human iPSCs disease models.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Disease Model</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">iPSC Source</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adrenoleukodistrophy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B47-jpm-10-00008">47</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Alzheimer’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B39-jpm-10-00008">39</xref>,<xref ref-type="bibr" rid="B48-jpm-10-00008">48</xref>,<xref ref-type="bibr" rid="B49-jpm-10-00008">49</xref>,<xref ref-type="bibr" rid="B50-jpm-10-00008">50</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Amyotrophic lateral sclerosis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts<break></break>Patient-derived peripheral blood mononuclear cells</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B40-jpm-10-00008">40</xref>,<xref ref-type="bibr" rid="B51-jpm-10-00008">51</xref>,<xref ref-type="bibr" rid="B52-jpm-10-00008">52</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Becker’s muscular dystrophy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B53-jpm-10-00008">53</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cardiovascular diseases</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B54-jpm-10-00008">54</xref>,<xref ref-type="bibr" rid="B55-jpm-10-00008">55</xref>,<xref ref-type="bibr" rid="B56-jpm-10-00008">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cockayne’s syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B57-jpm-10-00008">57</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Down’s syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B53-jpm-10-00008">53</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Duchenne muscular dystrophy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B53-jpm-10-00008">53</xref>,<xref ref-type="bibr" rid="B58-jpm-10-00008">58</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Familial dysautonomia</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B59-jpm-10-00008">59</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Fragile X-associated tremor/ataxia syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B60-jpm-10-00008">60</xref>,<xref ref-type="bibr" rid="B61-jpm-10-00008">61</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gaucher’s disease type III</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B53-jpm-10-00008">53</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Huntington’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B53-jpm-10-00008">53</xref>,<xref ref-type="bibr" rid="B62-jpm-10-00008">62</xref>,<xref ref-type="bibr" rid="B63-jpm-10-00008">63</xref>,<xref ref-type="bibr" rid="B64-jpm-10-00008">64</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Juvenile diabetes mellitus</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B53-jpm-10-00008">53</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LEOPARD syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B65-jpm-10-00008">65</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Machado-Joseph disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B66-jpm-10-00008">66</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lesch-Nyhan syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B53-jpm-10-00008">53</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parkinson’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B41-jpm-10-00008">41</xref>,<xref ref-type="bibr" rid="B67-jpm-10-00008">67</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pompe’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B68-jpm-10-00008">68</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Rett syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B69-jpm-10-00008">69</xref>,<xref ref-type="bibr" rid="B70-jpm-10-00008">70</xref>,<xref ref-type="bibr" rid="B71-jpm-10-00008">71</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prader-Willi syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B72-jpm-10-00008">72</xref>,<xref ref-type="bibr" rid="B73-jpm-10-00008">73</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B74-jpm-10-00008">74</xref>,<xref ref-type="bibr" rid="B75-jpm-10-00008">75</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Spinal muscular atrophy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B76-jpm-10-00008">76</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Timothy syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived fibroblasts</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B77-jpm-10-00008">77</xref>,<xref ref-type="bibr" rid="B78-jpm-10-00008">78</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The selective modification of cells’ genetic information was the groundbreaking discovery that revolutionized the concept of cell models. Innovative biotechnologies, together with other previously established, allowed the generation of pathological cells by introducing a defined mutation responsible for the onset of the disease (genome editing) as well as the restoration of a missing gene function in defective cells (gene therapy) (<xref ref-type="fig" rid="jpm-10-00008-f001">Figure 1</xref>). In the case of iPSCs or adult stem cells, they can afterwards be differentiated into diverse cell types involved in the pathology. Accordingly, it is plausible to be able to specifically study each pathological condition in each individual patient and consequently personalize the therapeutic approach (i.e., precision medicine) [<xref ref-type="bibr" rid="B79-jpm-10-00008">79</xref>], also with the support of gene therapy approaches and gene editing procedures.</p>
<p>Briefly, gene therapy can be achieved through the use of advanced viral vectors (e.g., lentiviral, adeno-associated, adenoviral, retroviral [<xref ref-type="bibr" rid="B80-jpm-10-00008">80</xref>,<xref ref-type="bibr" rid="B81-jpm-10-00008">81</xref>,<xref ref-type="bibr" rid="B82-jpm-10-00008">82</xref>,<xref ref-type="bibr" rid="B83-jpm-10-00008">83</xref>,<xref ref-type="bibr" rid="B84-jpm-10-00008">84</xref>,<xref ref-type="bibr" rid="B85-jpm-10-00008">85</xref>]) or non-viral vector systems (e.g., liposomes systems) [<xref ref-type="bibr" rid="B86-jpm-10-00008">86</xref>] that drive the therapeutic gene to the host cells [<xref ref-type="bibr" rid="B87-jpm-10-00008">87</xref>,<xref ref-type="bibr" rid="B88-jpm-10-00008">88</xref>,<xref ref-type="bibr" rid="B89-jpm-10-00008">89</xref>,<xref ref-type="bibr" rid="B90-jpm-10-00008">90</xref>,<xref ref-type="bibr" rid="B91-jpm-10-00008">91</xref>]. The safety and efficacy of these strategies may be evaluated in engineered stem cell models, that are suitable for the treatment validation and for the screening of potential mutational insertions caused by the integration of the target gene in the host DNA [<xref ref-type="bibr" rid="B92-jpm-10-00008">92</xref>,<xref ref-type="bibr" rid="B93-jpm-10-00008">93</xref>,<xref ref-type="bibr" rid="B94-jpm-10-00008">94</xref>,<xref ref-type="bibr" rid="B95-jpm-10-00008">95</xref>]. Thus, even if the use of animal models is still essential before these treatments reach the clinical phase, stem cells are an alternative models enable to test the effectiveness of treatments in a highly efficient, reproducible and fast manner [<xref ref-type="bibr" rid="B84-jpm-10-00008">84</xref>,<xref ref-type="bibr" rid="B85-jpm-10-00008">85</xref>,<xref ref-type="bibr" rid="B86-jpm-10-00008">86</xref>,<xref ref-type="bibr" rid="B90-jpm-10-00008">90</xref>,<xref ref-type="bibr" rid="B91-jpm-10-00008">91</xref>,<xref ref-type="bibr" rid="B96-jpm-10-00008">96</xref>]. For instance, in Adenosine Deaminase Activity (ADA-SCID) immunodeficiency therapy (Strimvelis, GlaxoSmithKline (GSK), approved by EMA in 2016 [<xref ref-type="bibr" rid="B97-jpm-10-00008">97</xref>]) ADA-genetically engineered hematopoietic stem cells served as basic cell model for validating the effectiveness of the gene delivery procedure and ultimately were used as therapeutic vehicle in vivo [<xref ref-type="bibr" rid="B97-jpm-10-00008">97</xref>]. With the same end, in Metachromatic Leukodystrophy, hematopoietic stem cells transduced with the ARSA gene were useful for establishing the restoration of the biochemical metabolic defect and were also used as vehicle for the ARSA gene in patients affected [<xref ref-type="bibr" rid="B80-jpm-10-00008">80</xref>,<xref ref-type="bibr" rid="B81-jpm-10-00008">81</xref>]. Moreover, ongoing studies are showing the relevance of engineered stem cells (e.g., iPSCs, mesenchymal stem cells) for the expression of trophic factors for the treatment of neurodegenerative disorders (Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis [<xref ref-type="bibr" rid="B98-jpm-10-00008">98</xref>]). Currently, many pathologies have been targets for gene therapy strategies and are being explored in clinical trials [<xref ref-type="bibr" rid="B81-jpm-10-00008">81</xref>,<xref ref-type="bibr" rid="B99-jpm-10-00008">99</xref>], or are already available for patients as they have obtained approval from the Food and Drug Administration (FDA) or the European Medicines Agency (EMA).</p>
<p>Genome editing can be achieved through the use of different nucleases that are able to introduce a double-strand break (DSB) in the double helix then resolved via non-homologous end joining (NHEJ) or homologous direct recombination (HDR). These molecular mechanisms are the bases of all the principal genome editing methods that, listed from the first used to the last discovered, are: Zinc finger nucleases (ZFNs, with specificity for 3 base pairs), transcription activator-like effector nucleases (TALENs, one base pair specificity) and the Clustered Regularly Interspaced Short Palindromic Repeat/Cas9 associated system (CRISPR/Cas9, single nucleotide specificity) [<xref ref-type="bibr" rid="B43-jpm-10-00008">43</xref>,<xref ref-type="bibr" rid="B100-jpm-10-00008">100</xref>]. While the first two approaches recognize the target sequence as a result of protein-DNA interactions, CRISPR/Cas9 system utilizes an RNA–DNA base pairing [<xref ref-type="bibr" rid="B100-jpm-10-00008">100</xref>]. CRISPR/Cas9 is widely considered to be the most promising tool for manipulating gene expression because, compared to TALENs, it is 3–6 times more cost-effective, it is a much easier technique and in vivo delivery is more effective, although it shows less specificity due to its susceptibility to off-targets [<xref ref-type="bibr" rid="B101-jpm-10-00008">101</xref>]. Specifically, CRISPR/Cas9 is engineered to edit DNA in stem cell models by designing specific guide RNA (gRNA) complementary to the target sequence (for extensive description see references [<xref ref-type="bibr" rid="B102-jpm-10-00008">102</xref>,<xref ref-type="bibr" rid="B103-jpm-10-00008">103</xref>,<xref ref-type="bibr" rid="B104-jpm-10-00008">104</xref>,<xref ref-type="bibr" rid="B105-jpm-10-00008">105</xref>,<xref ref-type="bibr" rid="B106-jpm-10-00008">106</xref>] and <xref ref-type="table" rid="jpm-10-00008-t003">Table 3</xref> for computational tools for the design of gRNA). This technique allows manipulation of any cell genome for creating a specific cell phenotype useful to establish accurate ex vivo cell disease models, as well as for correcting DNA mutations linked to pathologies when combined with gene therapy procedures.</p>
</sec>
<sec id="sec4-jpm-10-00008">
<title>4. Ex Vivo Stem Cell-Based Systems: Bio-Hybrid Models for Tissue Engineering</title>
<p>Tissue engineering applies the concepts of engineering and biology to develop scaffold-based systems with the aim of reproducing the structure and the physiological functions of healthy tissues. The use of stem cells and biomaterials allows the generation of ad hoc bio-hybrid systems that represent 3D-models of tissues either for disease modeling (<xref ref-type="fig" rid="jpm-10-00008-f001">Figure 1</xref>) or, after validation, for therapeutic transplantation [<xref ref-type="bibr" rid="B14-jpm-10-00008">14</xref>,<xref ref-type="bibr" rid="B37-jpm-10-00008">37</xref>,<xref ref-type="bibr" rid="B113-jpm-10-00008">113</xref>,<xref ref-type="bibr" rid="B114-jpm-10-00008">114</xref>].</p>
<p>These scaffold-based platforms rely on the mechanobiology concept by which biomaterials provide the 3D-structure of native tissues and through their chemical/physical properties are able to specifically steer stem cells toward tissue-specific phenotypes [<xref ref-type="bibr" rid="B14-jpm-10-00008">14</xref>]. As a matter of fact, the modulation of physical and chemical properties of biomaterials such as architecture, shape, mechanical properties, and surface structure, have been showed to control the biological responses of stem cells (both stemness and differentiation properties) [<xref ref-type="bibr" rid="B113-jpm-10-00008">113</xref>,<xref ref-type="bibr" rid="B115-jpm-10-00008">115</xref>,<xref ref-type="bibr" rid="B116-jpm-10-00008">116</xref>]. Many types of natural or synthetic biomaterials, such as polymers, ceramics, bio-glass, composites, or seldom metals [<xref ref-type="bibr" rid="B37-jpm-10-00008">37</xref>,<xref ref-type="bibr" rid="B117-jpm-10-00008">117</xref>,<xref ref-type="bibr" rid="B118-jpm-10-00008">118</xref>,<xref ref-type="bibr" rid="B119-jpm-10-00008">119</xref>,<xref ref-type="bibr" rid="B120-jpm-10-00008">120</xref>,<xref ref-type="bibr" rid="B121-jpm-10-00008">121</xref>,<xref ref-type="bibr" rid="B122-jpm-10-00008">122</xref>,<xref ref-type="bibr" rid="B123-jpm-10-00008">123</xref>], have been combined with different types of stem cells in order to faithfully recapitulate key environmental signals (thus allowing finer cell/tissue models [<xref ref-type="bibr" rid="B11-jpm-10-00008">11</xref>,<xref ref-type="bibr" rid="B124-jpm-10-00008">124</xref>]) and elucidate complex biological phenomena such as stem cell reprogramming pathways and determination processes [<xref ref-type="bibr" rid="B14-jpm-10-00008">14</xref>]. To date, some tissue engineering strategies have already reached the market and are used as personalized therapies. (<xref ref-type="table" rid="jpm-10-00008-t004">Table 4</xref>) [<xref ref-type="bibr" rid="B125-jpm-10-00008">125</xref>,<xref ref-type="bibr" rid="B126-jpm-10-00008">126</xref>]. For example, many types of skin substitutes, acellular or cellular, are currently available for the treatment of wounds, while both cryopreserved placental membrane and human fibroblasts-derived substitute (HFDs) are approved for the therapy of diabetic foot ulcers [<xref ref-type="bibr" rid="B127-jpm-10-00008">127</xref>] (<xref ref-type="table" rid="jpm-10-00008-t004">Table 4</xref>). Moreover, autologous cartilage cells are used in a phase III clinical trial for the treatment of articular cartilage defects [<xref ref-type="bibr" rid="B128-jpm-10-00008">128</xref>] (<xref ref-type="table" rid="jpm-10-00008-t004">Table 4</xref>).</p>
<p>Among the many scaffold fabrication methods, 3D-bioprinting has recently received a great deal of attention as one of the best tool to obtain specific precise architecture and biochemical composition of biocompatible materials and supporting components [<xref ref-type="bibr" rid="B135-jpm-10-00008">135</xref>]. With this technique it could be possible to faithfully recreate native tissue cellular composition, vasculature, and architecture in vitro, thus making biomimetic tissue models, which could then be used for studying disease mechanisms, drug screening, and clinical applications [<xref ref-type="bibr" rid="B136-jpm-10-00008">136</xref>,<xref ref-type="bibr" rid="B137-jpm-10-00008">137</xref>].</p>
<p>Accordingly, 3D-bioprinting was used for generating in vitro disease models of tumor microenvironments [<xref ref-type="bibr" rid="B138-jpm-10-00008">138</xref>], ovarian cancer [<xref ref-type="bibr" rid="B139-jpm-10-00008">139</xref>], and drug testing [<xref ref-type="bibr" rid="B140-jpm-10-00008">140</xref>]. Even though bioprinting of tissues and organs gave new possibilities to tissue engineering and regenerative medicine [<xref ref-type="bibr" rid="B136-jpm-10-00008">136</xref>], their translational application is still facing some challenges. As a matter of fact, current obstacles in 3D-bioprinting methods are the poor scalability, the improvement of bioinks with appropriate biological and mechanical properties suitable to different cell types and the absence of vascularization that cause hurdles in nutrients supply, other than regulatory aspects [<xref ref-type="bibr" rid="B141-jpm-10-00008">141</xref>]. Nevertheless, research in 3D-bioprinting technology is advancing and these limitations will be overcome [<xref ref-type="bibr" rid="B141-jpm-10-00008">141</xref>].</p>
</sec>
<sec id="sec5-jpm-10-00008">
<title>5. Ex Vivo Stem Cell-Based Systems: Organoids</title>
<p>In recent years, progress in 3D-stem cell cultures led to the production of new systems with great potential as cell model platforms (<xref ref-type="fig" rid="jpm-10-00008-f001">Figure 1</xref>). These models have been called organoids, because of their ability to resemble organs, and are characterized by (i) 3D-structure, (ii) different types of cells normally present in the organ that should be modelled, (iii) functional features of the organ, and (iv) self-organization [<xref ref-type="bibr" rid="B142-jpm-10-00008">142</xref>]. Self-organization is indeed the most important characteristic of organoids: Under opportune culture conditions (appropriate nutrients and growth factors) primary cells isolated from biopsies, embryonic or adult stem cells, and patient-derived iPSCs can go towards differentiation to develop a ‘mini’ organ according to intrinsic developmental patterns, thus generating a faithful replica of tissues’ morphology and organization [<xref ref-type="bibr" rid="B142-jpm-10-00008">142</xref>,<xref ref-type="bibr" rid="B143-jpm-10-00008">143</xref>]. Therefore, organoids hold a great promise for ex vivo cell modeling as they are a powerful tool for developmental studies and personalized medicine [<xref ref-type="bibr" rid="B144-jpm-10-00008">144</xref>]. Accordingly, organoids represent a major improvement in disease modeling compared to animal models, as they overcome ethical issues, are more cost-effective and allow faster analysis [<xref ref-type="bibr" rid="B144-jpm-10-00008">144</xref>,<xref ref-type="bibr" rid="B145-jpm-10-00008">145</xref>]. Since the development of the first intestinal organoids by Sato and collaborators in 2009 [<xref ref-type="bibr" rid="B146-jpm-10-00008">146</xref>], many other models of various tissues have been developed following diverse approaches such as (i) Matrigel scaffold-based, (ii) Embryoid Bodies (EB)-based, and (iii) Air–Liquid Interface (ALI) method [<xref ref-type="bibr" rid="B147-jpm-10-00008">147</xref>], and they have been used to model a great range of pathologies, from viral infection to solid cancers, cystic fibrosis, and endometriosis (<xref ref-type="table" rid="jpm-10-00008-t005">Table 5</xref>). Even if in the last decade efforts have been made for improving organoids fidelity to the in vivo counterpart [<xref ref-type="bibr" rid="B148-jpm-10-00008">148</xref>], there are still several critical aspects that have to be taken into account when evaluating organoids predictability. In particular, there is poor control on the shape, size and cells appropriate organization, causing hurdles in terms of scalability and high-throughput approaches. All these variables are mainly arising from a lack of nutrients supply due to the absence of physiological vascularization, which causes the inner part of the organoid to suffer metabolic stress and go towards incorrect differentiation or death [<xref ref-type="bibr" rid="B142-jpm-10-00008">142</xref>,<xref ref-type="bibr" rid="B143-jpm-10-00008">143</xref>,<xref ref-type="bibr" rid="B149-jpm-10-00008">149</xref>]. Although these limitations are slowing down organoids’ clinical applications, they are still considered one of the best options currently available to build a strong cell model capable of summarizing key features of many diseases.</p>
</sec>
<sec id="sec6-jpm-10-00008">
<title>6. Ex Vivo Stem Cell-Based Systems: Organs-on-a-Chip</title>
<p>A more recent advance in stem cell biology and 3D-tissue engineering is the innovative application of microfluidic techniques for the development of organ-on-a-chip platforms (OOC) (<xref ref-type="fig" rid="jpm-10-00008-f001">Figure 1</xref>). The rationale of the introduction of microfluidic in cell cultures is to reproduce the microenvironment of cells through the use of precise control on fluid flow, biochemical factors and mechanical forces [<xref ref-type="bibr" rid="B198-jpm-10-00008">198</xref>]. The aim of OOCs is to reproduce in vitro functional units of organs by reproducing the essential elements that allow physiological functions [<xref ref-type="bibr" rid="B199-jpm-10-00008">199</xref>]. This is achieved by the use of micro-fabricated cell culture devices designed to replicate the fundamental architectural characteristics of the organ in exam, which incorporate microchambers and microchannels that allow the growth of diverse cell types in defined culture condition thanks to the capillary controlled fluid flow. Moreover, the tailor-made architectural organization of OOCs enables to study the interactions between different biological compartments, such as cells and the extracellular matrix (ECM), tissue–tissue interfaces and parenchymal-vascular association [<xref ref-type="bibr" rid="B199-jpm-10-00008">199</xref>,<xref ref-type="bibr" rid="B200-jpm-10-00008">200</xref>]. One of the most important aspects of OOCs is that it is possible to combine different biomaterials, microfabrication techniques (extensively reviewed in [<xref ref-type="bibr" rid="B201-jpm-10-00008">201</xref>,<xref ref-type="bibr" rid="B202-jpm-10-00008">202</xref>]) and cell types for creating multi-compartment and multiphysiological systems that can model tissues pathophysiology. These systems can be developed for reflecting individual pathophysiological conditions by including blood samples, patient-derived primary adult stem cells or iPSCs and by adjusting physiochemical parameters of the flow according to personal health data [<xref ref-type="bibr" rid="B203-jpm-10-00008">203</xref>] (<xref ref-type="fig" rid="jpm-10-00008-f001">Figure 1</xref>). This personalized strategy could thus be the new frontier for building a tailored cell disease model able to take into account individual pathological variability and, in this way, personalizing treatments [<xref ref-type="bibr" rid="B203-jpm-10-00008">203</xref>]. The possibility of harnessing stem cells versatility, differentiated cells specific properties and microfluidic control allowed to build disease models with unprecedented features, as it made possible to reproduce in vitro complex biological structures that could not be obtained with previous cell culturing technologies such as the blood–brain barrier [<xref ref-type="bibr" rid="B204-jpm-10-00008">204</xref>] (<xref ref-type="table" rid="jpm-10-00008-t006">Table 6</xref>). As a matter of fact, in the past five years many disease models have been developed, such as lung-on-a-chip for cancer [<xref ref-type="bibr" rid="B205-jpm-10-00008">205</xref>] or coupled-OOCs of liver and pancreas spheroids able to maintain glucose homeostasis for modeling type 2 diabetes [<xref ref-type="bibr" rid="B206-jpm-10-00008">206</xref>] (<xref ref-type="table" rid="jpm-10-00008-t006">Table 6</xref>). Of note, different OOC models can be linked to build an ideal ‘human-on-a-chip’ which could theoretically serve as the ultimate alternative to animal models for its capacity to predict multiorgan biological interactions and response to therapeutic treatments [<xref ref-type="bibr" rid="B202-jpm-10-00008">202</xref>,<xref ref-type="bibr" rid="B207-jpm-10-00008">207</xref>].</p>
<p>In spite of the many advantages that OOCs have, they rely on the ability of the scientist to artificially reconstruct the correct microenvironment using the correct cell types and arranging them as they would be in the physiological state. Therefore, future perspective of 3D cell modeling will involve the synergic combination of OOCs and organoids, for the possibility of precisely control microenvironmental conditions and exploit organoids self-organization, with the aim of obtaining the best ex vivo cell modeling technology [<xref ref-type="bibr" rid="B208-jpm-10-00008">208</xref>].</p>
<table-wrap id="jpm-10-00008-t006" orientation="portrait" position="float">
<object-id pub-id-type="pii">jpm-10-00008-t006_Table 6</object-id>
<label>Table 6</label>
<caption>
<p>List of human organ-on-a-chip disease models.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Organ</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Disease</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Model Derivation</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">BRAIN</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Alzheimer’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial neural progenitor cells and commercial microglia cell line</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B204-jpm-10-00008">204</xref>,<xref ref-type="bibr" rid="B209-jpm-10-00008">209</xref>,<xref ref-type="bibr" rid="B210-jpm-10-00008">210</xref>,<xref ref-type="bibr" rid="B211-jpm-10-00008">211</xref>,<xref ref-type="bibr" rid="B212-jpm-10-00008">212</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Blood–brain barrier dysfunctions</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial cell lines (endothelial cells, brain pericytes, astrocytes) and healthy donors-derived iPSCs</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neuroinflammation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial cell lines (endothelial cells, brain pericytes, astrocytes)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Brain cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial glioblastoma cells</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">HEART</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mitochondrial cardiomyopathy of Barth syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients-derived iPSCs</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B213-jpm-10-00008">213</xref>,<xref ref-type="bibr" rid="B214-jpm-10-00008">214</xref>,<xref ref-type="bibr" rid="B215-jpm-10-00008">215</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Chronic drug exposure</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial human embryonic stem cells</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">KIDNEY</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Antibiotic nephrotoxicity</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Healthy donors human kidney tissues</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B216-jpm-10-00008">216</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">LIVER</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hepatitis B infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial HepDE19 cells, Primary human hepatocytes, Kupffer Cells, HepG2 cells</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B217-jpm-10-00008">217</xref>,<xref ref-type="bibr" rid="B218-jpm-10-00008">218</xref>,<xref ref-type="bibr" rid="B219-jpm-10-00008">219</xref>,<xref ref-type="bibr" rid="B220-jpm-10-00008">220</xref>,<xref ref-type="bibr" rid="B221-jpm-10-00008">221</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Drug hepatotoxicity</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial HepG2 cells, human umbilical vein cells (EAhy926), human stellate cells (LX-2), human histiocytic lymphoma (U937) and basement membrane extract</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Drug hepatotoxicity</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial primary human hepatocytes, monoblast derived Kupfer cells, stellate cells (LX-2), human dermal microvascular endothelial cells and isolated primary human polymorphonuclear leukocytes from healthy donors</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Non-alcoholic fatty liver disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial HepG2 cells</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">LUNG</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Protein-induced lung inflammation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial bronchial epithelial cell line and healthy donors fibrocytes</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B205-jpm-10-00008">205</xref>,<xref ref-type="bibr" rid="B222-jpm-10-00008">222</xref>,<xref ref-type="bibr" rid="B223-jpm-10-00008">223</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Idiopathic pulmonary fibrosis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial alveolar epithelial-like cells</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lung cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial non-small cell lung cancer cells and commercial human fetal lung fibroblasts</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec7-jpm-10-00008" sec-type="conclusions">
<title>7. Conclusions</title>
<p>In this review, we have documented the significant improvements in disease modeling using human adult stem cells and iPSCs, highlighting how their contribution in generating more elaborated 3D-models (organoids, organ-on-a-chip, and bio-hybrid systems) have greatly facilitated our understanding and ability to treat human disease. Noteworthy, we have also pointed out that the tremendous advancement of the field has highlighted the need for these models to be accurate, efficient and safe, in order to accomplish valid differentiation protocols and development of effective therapies. In this regard, computational tools able to predict complex biological systems, together with genome editing and gene therapy technologies support researchers in the development of more proficient disease models. Collectively, the issues discussed emphasized ex vivo-stem cell models as an alternative or complementary system to animal disease models.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank all researchers cited in this review and we apologize to colleagues in the field for not being able to cite many important papers due to the limitation of the article.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, C.A., I.T., M.B., F.M., and S.M.; Software, F.M.; Writing—Review and Editing, C.A., I.T., M.B., F.M., and S.M.; Supervision, S.M.; Funding Acquisition, S.M. All authors have read and agreed to the published version of the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>This research was funded by grant Fondo Ricerca di Base 2017, DCBB, University of Perugia, Italy and grant by FFABRMARTINO-2018 from MIUR, Italy, awarded to S.M.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-jpm-10-00008">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGonigle</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ruggeri</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Animal models of human disease: Challenges in enabling translation</article-title>
<source/>Biochem. Pharmacol.
          <year>2014</year>
<volume>87</volume>
<fpage>162</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2013.08.006</pub-id>
<pub-id pub-id-type="pmid">23954708</pub-id>
</element-citation>
</ref>
<ref id="B2-jpm-10-00008">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartung</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Thoughts on limitations of animal models</article-title>
<source/>Park. Relat. Disord.
          <year>2008</year>
<volume>14</volume>
<fpage>S81</fpage>
<lpage>S83</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2008.04.003</pub-id>
</element-citation>
</ref>
<ref id="B3-jpm-10-00008">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mak</surname>
<given-names>I.W.Y.</given-names>
</name>
<name>
<surname>Evaniew</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ghert</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Lost in translation: Animal models and clinical trials in cancer treatment</article-title>
<source/>Am. J. Transl. Res.
          <year>2014</year>
<volume>6</volume>
<fpage>114</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="pmid">24489990</pub-id>
</element-citation>
</ref>
<ref id="B4-jpm-10-00008">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawson</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Animal models of GM2 gangliosidosis: Utility and limitations</article-title>
<source/>Appl. Clin. Genet.
          <year>2016</year>
<volume>9</volume>
<fpage>111</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.2147/TACG.S85354</pub-id>
<pub-id pub-id-type="pmid">27499644</pub-id>
</element-citation>
</ref>
<ref id="B5-jpm-10-00008">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tannenbaum</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>Russell and Burch’s 3Rs then and now: The need for clarity in definition and purpose</article-title>
<source/>J. Am. Assoc. Lab. Anim. Sci.
          <year>2015</year>
<volume>54</volume>
<fpage>120</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="pmid">25836957</pub-id>
</element-citation>
</ref>
<ref id="B6-jpm-10-00008">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swain</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Basic Techniques and Limitations in Establishing Cell Culture: A Mini Review</article-title>
<source/>Adv. Anim. Vet. Sci.
          <year>2014</year>
<volume>2</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.14737/journal.aavs/2014/2.4s.1.10</pub-id>
</element-citation>
</ref>
<ref id="B7-jpm-10-00008">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapałczyńska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kolenda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Przybyła</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zajączkowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Teresiak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Filas</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ibbs</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bliźniak</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Łuczewski</surname>
<given-names>Ł.</given-names>
</name>
<name>
<surname>Lamperska</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>2D and 3D cell cultures–A comparison of different types of cancer cell cultures</article-title>
<source/>Arch. Med. Sci.
          <year>2018</year>
<volume>14</volume>
<fpage>910</fpage>
<lpage>919</lpage>
<pub-id pub-id-type="doi">10.5114/aoms.2016.63743</pub-id>
<pub-id pub-id-type="pmid">30002710</pub-id>
</element-citation>
</ref>
<ref id="B8-jpm-10-00008">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Argentati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bazzucchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Above the Epitranscriptome: RNA Modifications and Stem Cell Identity</article-title>
<source/>Genes
          <year>2018</year>
<volume>9</volume>
<elocation-id>329</elocation-id>
<pub-id pub-id-type="doi">10.3390/genes9070329</pub-id>
</element-citation>
</ref>
<ref id="B9-jpm-10-00008">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Argentati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Trotta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Crispoltoni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stabile</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pistilli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>di Baldassarre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calafiore</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Montanucci</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Basta</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer’s disease and MCI patients: Implications for regenerative medicine approaches</article-title>
<source/>Int. J. Mol. Sci.
          <year>2017</year>
<volume>18</volume>
<elocation-id>1806</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms18081806</pub-id>
</element-citation>
</ref>
<ref id="B10-jpm-10-00008">
<label>10.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Saji Joseph</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tebogo Malindisa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ntwasa</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Two-Dimensional (2D) and Three-Dimensional (3D) Cell Culturing in Drug Discovery</article-title>
<source/>Cell Culture
          <publisher-name>IntechOpen</publisher-name>
<publisher-loc>Rijeka, Croatia</publisher-loc>
<year>2019</year>
</element-citation>
</ref>
<ref id="B11-jpm-10-00008">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Ingber</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>From 3D cell culture to organs-on-chips</article-title>
<source/>Trends Cell Biol.
          <year>2011</year>
<volume>21</volume>
<fpage>745</fpage>
<lpage>754</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2011.09.005</pub-id>
<pub-id pub-id-type="pmid">22033488</pub-id>
</element-citation>
</ref>
<ref id="B12-jpm-10-00008">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Eglen</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Three-Dimensional Cell Cultures in Drug Discovery and Development</article-title>
<source/>SLAS Discov.
          <year>2017</year>
<volume>22</volume>
<fpage>456</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="pmid">28520521</pub-id>
</element-citation>
</ref>
<ref id="B13-jpm-10-00008">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paramesh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kaviya</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Anuradha</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Paul Solomon</surname>
<given-names>F.D.</given-names>
</name>
</person-group>
<article-title>3D cell culture systems: Advantages and applications</article-title>
<source/>J. Cell. Physiol.
          <year>2015</year>
<volume>230</volume>
<fpage>16</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.24683</pub-id>
<pub-id pub-id-type="pmid">24912145</pub-id>
</element-citation>
</ref>
<ref id="B14-jpm-10-00008">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argentati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tortorella</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bazzucchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Porcellati</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Insight into Mechanobiology: How Stem Cells Feel Mechanical Forces and Orchestrate Biological Functions</article-title>
<source/>Int. J. Mol. Sci.
          <year>2019</year>
<volume>20</volume>
<elocation-id>5337</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20215337</pub-id>
</element-citation>
</ref>
<ref id="B15-jpm-10-00008">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cukierman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pankov</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Cell interactions with three-dimensional matrices</article-title>
<source/>Curr. Opin. Cell Biol.
          <year>2002</year>
<volume>14</volume>
<fpage>633</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="doi">10.1016/S0955-0674(02)00364-2</pub-id>
<pub-id pub-id-type="pmid">12231360</pub-id>
</element-citation>
</ref>
<ref id="B16-jpm-10-00008">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luca</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Mersch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Deenen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Messner</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Schäfer</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Baldus</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Huckenbeck</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Piekorz</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Knoefel</surname>
<given-names>W.T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell Lines</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e59689</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0059689</pub-id>
<pub-id pub-id-type="pmid">23555746</pub-id>
</element-citation>
</ref>
<ref id="B17-jpm-10-00008">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myungjin Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mhawech-Fauceglia</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cristina Parsanian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gail Lin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Andrew Gayther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lawrenson</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro</article-title>
<source/>Lab. Investig.
          <year>2013</year>
<volume>93</volume>
<fpage>528</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1038/labinvest.2013.41</pub-id>
<pub-id pub-id-type="pmid">23459371</pub-id>
</element-citation>
</ref>
<ref id="B18-jpm-10-00008">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edmondson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Broglie</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Adcock</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Three-Dimensional cell culture systems and their applications in drug discovery and cell-based biosensors</article-title>
<source/>Assay Drug Dev. Technol.
          <year>2014</year>
<volume>12</volume>
<fpage>207</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1089/adt.2014.573</pub-id>
<pub-id pub-id-type="pmid">24831787</pub-id>
</element-citation>
</ref>
<ref id="B19-jpm-10-00008">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knight</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Przyborski</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro</article-title>
<source/>J. Anat.
          <year>2015</year>
<volume>227</volume>
<fpage>746</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="doi">10.1111/joa.12257</pub-id>
<pub-id pub-id-type="pmid">25411113</pub-id>
</element-citation>
</ref>
<ref id="B20-jpm-10-00008">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machado</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>TidRocha</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Modeling formalisms in systems biology</article-title>
<source/>AMB Express
          <year>2011</year>
<volume>1</volume>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1186/2191-0855-1-45</pub-id>
<pub-id pub-id-type="pmid">21906327</pub-id>
</element-citation>
</ref>
<ref id="B21-jpm-10-00008">
<label>21.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Papatsenko</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lemischka</surname>
<given-names>I.R.</given-names>
</name>
</person-group>
<article-title>Emerging Modeling Concepts and Solutions in Stem Cell Research</article-title>
<source/>Current Topics in Developmental Biology
          <publisher-name>Academic Press Inc.</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2016</year>
<fpage>709</fpage>
<lpage>721</lpage>
<isbn>9780128029565</isbn>
</element-citation>
</ref>
<ref id="B22-jpm-10-00008">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calzone</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fages</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Soliman</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>BIOCHAM: An environment for modeling biological systems and formalizing experimental knowledge</article-title>
<source/>Bioinformatics
          <year>2006</year>
<volume>22</volume>
<fpage>805</fpage>
<lpage>1807</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btl172</pub-id>
</element-citation>
</ref>
<ref id="B23-jpm-10-00008">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Feidler</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>BioSPICE: A Computational Infrastructure for Integrative Biology</article-title>
<source/>Omi. A J. Integr. Biol.
          <year>2003</year>
<volume>7</volume>
<fpage>225</fpage>
<pub-id pub-id-type="doi">10.1089/153623103322452350</pub-id>
<pub-id pub-id-type="pmid">14583112</pub-id>
</element-citation>
</ref>
<ref id="B24-jpm-10-00008">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuellar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hedley</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Halstead</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bullivant</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nickerson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The CellML 1.1 Specification</article-title>
<source/>J. Integr. Bioinform.
          <year>2015</year>
<volume>12</volume>
<fpage>259</fpage>
<pub-id pub-id-type="doi">10.1515/jib-2015-259</pub-id>
<pub-id pub-id-type="pmid">26528557</pub-id>
</element-citation>
</ref>
<ref id="B25-jpm-10-00008">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergmann</surname>
<given-names>F.T.</given-names>
</name>
<name>
<surname>Hoops</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Klahn</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kummer</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pahle</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sahle</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>COPASI and its applications in biotechnology</article-title>
<source/>J. Biotechnol.
          <year>2017</year>
<volume>261</volume>
<fpage>215</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1016/j.jbiotec.2017.06.1200</pub-id>
<pub-id pub-id-type="pmid">28655634</pub-id>
</element-citation>
</ref>
<ref id="B26-jpm-10-00008">
<label>26.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Arjunan</surname>
<given-names>S.N.</given-names>
</name>
</person-group>
<source/>A Guide to Modeling Reaction-Diffusion of Molecules with the E-Cell System
          <publisher-name>Springer</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2013</year>
</element-citation>
</ref>
<ref id="B27-jpm-10-00008">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sütterlin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kolb</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dickhaus</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jäger</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Grabe</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Bridging the scales: Semantic integration of quantitative SBML in graphical multi-cellular models and simulations with EPISIM and COPASI</article-title>
<source/>Bioinformatics
          <year>2013</year>
<volume>29</volume>
<fpage>223</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts659</pub-id>
<pub-id pub-id-type="pmid">23162085</pub-id>
</element-citation>
</ref>
<ref id="B28-jpm-10-00008">
<label>28.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Tapia</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Saglam</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Czech</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuczewski</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bartol</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Sejnowski</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Faeder</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>MCell-R: A Particle-Resolution Network-Free Spatial Modeling Framework</article-title>
<source/>Methods in Molecular Biology
          <publisher-name>Humana Press Inc.</publisher-name>
<publisher-loc>Totowa, NJ, USA</publisher-loc>
<year>2019</year>
<fpage>203</fpage>
<lpage>229</lpage>
</element-citation>
</ref>
<ref id="B29-jpm-10-00008">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerr</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Bartol</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Kaminsky</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dittrich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J.C.J.</given-names>
</name>
<name>
<surname>Baden</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Sejnowski</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Stiles</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Fast Monte Carlo simulation methods for biological reaction-diffusion systems in solution and on surfaces</article-title>
<source/>SIAM J. Sci. Comput.
          <year>2008</year>
<volume>30</volume>
<fpage>3126</fpage>
<lpage>3149</lpage>
<pub-id pub-id-type="doi">10.1137/070692017</pub-id>
<pub-id pub-id-type="pmid">20151023</pub-id>
</element-citation>
</ref>
<ref id="B30-jpm-10-00008">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starruß</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>De Back</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Brusch</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Deutsch</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Morpheus: A user-friendly modeling environment for multiscale and multicellular systems biology</article-title>
<source/>Bioinformatics
          <year>2014</year>
<volume>30</volume>
<fpage>1331</fpage>
<lpage>1332</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btt772</pub-id>
<pub-id pub-id-type="pmid">24443380</pub-id>
</element-citation>
</ref>
<ref id="B31-jpm-10-00008">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merks</surname>
<given-names>R.M.H.</given-names>
</name>
<name>
<surname>Glazier</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>A cell-centered approach to developmental biology</article-title>
<source/>Phys. A Stat. Mech. Appl.
          <year>2005</year>
<volume>352</volume>
<fpage>113</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1016/j.physa.2004.12.028</pub-id>
</element-citation>
</ref>
<ref id="B32-jpm-10-00008">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Resasco</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Novak</surname>
<given-names>I.L.</given-names>
</name>
<name>
<surname>Schaff</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Slepchenko</surname>
<given-names>B.M.</given-names>
</name>
</person-group>
<article-title>Virtual Cell: Computational tools for modeling in cell biology</article-title>
<source/>Wiley Interdiscip. Rev. Syst. Biol. Med.
          <year>2012</year>
<volume>4</volume>
<fpage>129</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1002/wsbm.165</pub-id>
<pub-id pub-id-type="pmid">22139996</pub-id>
</element-citation>
</ref>
<ref id="B33-jpm-10-00008">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sterneckert</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Reinhardt</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schöler</surname>
<given-names>H.R.</given-names>
</name>
</person-group>
<article-title>Investigating human disease using stem cell models</article-title>
<source/>Nat. Rev. Genet.
          <year>2014</year>
<volume>15</volume>
<fpage>625</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3764</pub-id>
<pub-id pub-id-type="pmid">25069490</pub-id>
</element-citation>
</ref>
<ref id="B34-jpm-10-00008">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>M.H.</given-names>
</name>
</person-group>
<article-title>Establishment in culture of pluripotential cells from mouse embryos</article-title>
<source/>Nature
          <year>1981</year>
<volume>292</volume>
<fpage>154</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1038/292154a0</pub-id>
<pub-id pub-id-type="pmid">7242681</pub-id>
</element-citation>
</ref>
<ref id="B35-jpm-10-00008">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>J.Z.</given-names>
</name>
<name>
<surname>Hockemeyer</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Human stem cell-based disease modeling: Prospects and challenges</article-title>
<source/>Curr. Opin. Cell Biol.
          <year>2015</year>
<volume>37</volume>
<fpage>84</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceb.2015.10.007</pub-id>
<pub-id pub-id-type="pmid">26546888</pub-id>
</element-citation>
</ref>
<ref id="B36-jpm-10-00008">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Girolamo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Cavazzin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tiribuzi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rivaroli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Valsecchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sandhoff</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sonnino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vescovi</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology</article-title>
<source/>J. Neurochem.
          <year>2009</year>
<volume>109</volume>
<fpage>135</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.05919.x</pub-id>
<pub-id pub-id-type="pmid">19166507</pub-id>
</element-citation>
</ref>
<ref id="B37-jpm-10-00008">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argentati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bazzucchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Armentano</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Adipose stem cell translational applications: From bench-to-bedside</article-title>
<source/>Int. J. Mol. Sci.
          <year>2018</year>
<volume>19</volume>
<elocation-id>3475</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19113475</pub-id>
<pub-id pub-id-type="pmid">30400641</pub-id>
</element-citation>
</ref>
<ref id="B38-jpm-10-00008">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ohnuki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Narita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ichisaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tomoda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors</article-title>
<source/>Cell
          <year>2007</year>
<volume>131</volume>
<fpage>861</fpage>
<lpage>872</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.11.019</pub-id>
<pub-id pub-id-type="pmid">18035408</pub-id>
</element-citation>
</ref>
<ref id="B39-jpm-10-00008">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Israel</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Bardy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reyna</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Herrera</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hefferan</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Van Gorp</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nazor</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Boscolo</surname>
<given-names>F.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells</article-title>
<source/>Nature
          <year>2012</year>
<volume>482</volume>
<fpage>216</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1038/nature10821</pub-id>
<pub-id pub-id-type="pmid">22278060</pub-id>
</element-citation>
</ref>
<ref id="B40-jpm-10-00008">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimos</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Rodolfa</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Niakan</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Weisenthal</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Mitsumoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Croft</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Saphier</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Leibel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goland</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons</article-title>
<source/>Science
          <year>2008</year>
<volume>321</volume>
<fpage>1218</fpage>
<lpage>1221</lpage>
<pub-id pub-id-type="doi">10.1126/science.1158799</pub-id>
<pub-id pub-id-type="pmid">18669821</pub-id>
</element-citation>
</ref>
<ref id="B41-jpm-10-00008">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devine</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Ryten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vodicka</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Burdon</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Houlden</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cavaleri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nagano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Taanman</surname>
<given-names>J.W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Parkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus</article-title>
<source/>Nat. Commun.
          <year>2011</year>
<volume>2</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1038/ncomms1453</pub-id>
</element-citation>
</ref>
<ref id="B42-jpm-10-00008">
<label>42.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Duelen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Corvelyn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tortorella</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Leonardi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Sampaolesi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Medicinal Biotechnology for Disease Modeling, Clinical Therapy, and Drug Discovery and Development</article-title>
<source/>Introduction to Biotech Entrepreneurship: From Idea to Business
          <publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham, Switzerland</publisher-loc>
<year>2019</year>
<fpage>89</fpage>
<lpage>128</lpage>
</element-citation>
</ref>
<ref id="B43-jpm-10-00008">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Targeted Genome Editing Tools for Disease Modeling and Gene Therapy</article-title>
<source/>Curr. Gene Ther.
          <year>2014</year>
<volume>14</volume>
<fpage>2</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.2174/156652321402140318165450</pub-id>
<pub-id pub-id-type="pmid">24665839</pub-id>
</element-citation>
</ref>
<ref id="B44-jpm-10-00008">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zomer</surname>
<given-names>H.D.</given-names>
</name>
<name>
<surname>Vidane</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Gonçalves</surname>
<given-names>N.N.</given-names>
</name>
<name>
<surname>Ambrósio</surname>
<given-names>C.E.</given-names>
</name>
</person-group>
<article-title>Mesenchymal and induced pluripotent stem cells: General insights and clinical perspectives</article-title>
<source/>Stem Cells Cloning Adv. Appl.
          <year>2015</year>
<volume>8</volume>
<fpage>125</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="doi">10.1016/S1525-0016(16)34271-X</pub-id>
</element-citation>
</ref>
<ref id="B45-jpm-10-00008">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frati</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Luciani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meneghini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>De Cicco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ståhlman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blomqvist</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Filocamo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Menegon</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy</article-title>
<source/>Cell Death Dis.
          <year>2018</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1038/s41419-018-0737-0</pub-id>
<pub-id pub-id-type="pmid">29298988</pub-id>
</element-citation>
</ref>
<ref id="B46-jpm-10-00008">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meneghini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Frati</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sala</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Cicco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Luciani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cavazzin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Paulis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mentzen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Giannelli</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy</article-title>
<source/>Stem Cells Transl. Med.
          <year>2017</year>
<volume>6</volume>
<fpage>352</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.5966/sctm.2015-0414</pub-id>
<pub-id pub-id-type="pmid">28191778</pub-id>
</element-citation>
</ref>
<ref id="B47-jpm-10-00008">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients</article-title>
<source/>Ann. Neurol.
          <year>2011</year>
<volume>70</volume>
<fpage>402</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="doi">10.1002/ana.22486</pub-id>
<pub-id pub-id-type="pmid">21721033</pub-id>
</element-citation>
</ref>
<ref id="B48-jpm-10-00008">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Asai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsukita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kutoku</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohsawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sunada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Imamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Egawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yahata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Okita</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness</article-title>
<source/>Cell Stem Cell
          <year>2013</year>
<volume>12</volume>
<fpage>487</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2013.01.009</pub-id>
<pub-id pub-id-type="pmid">23434393</pub-id>
</element-citation>
</ref>
<ref id="B49-jpm-10-00008">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essayan-Perez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nabet</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Wernig</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.W.A.</given-names>
</name>
</person-group>
<article-title>Modeling Alzheimer’s disease with human iPS cells: Advancements, lessons, and applications</article-title>
<source/>Neurobiol. Dis.
          <year>2019</year>
<volume>130</volume>
<fpage>104503</fpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2019.104503</pub-id>
<pub-id pub-id-type="pmid">31202913</pub-id>
</element-citation>
</ref>
<ref id="B50-jpm-10-00008">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mungenast</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Siegert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>Modeling Alzheimer’s disease with human induced pluripotent stem (iPS) cells</article-title>
<source/>Mol. Cell. Neurosci.
          <year>2016</year>
<volume>73</volume>
<fpage>13</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2015.11.010</pub-id>
<pub-id pub-id-type="pmid">26657644</pub-id>
</element-citation>
</ref>
<ref id="B51-jpm-10-00008">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kitaoka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tsukita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Naitoh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Okita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Asaka</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Drug screening for ALS using patient-specific induced pluripotent stem cells</article-title>
<source/>Sci. Transl. Med.
          <year>2012</year>
<volume>4</volume>
<fpage>145ra104</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3004052</pub-id>
<pub-id pub-id-type="pmid">22855461</pub-id>
</element-citation>
</ref>
<ref id="B52-jpm-10-00008">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bossolasco</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sassone</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gumina</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Peverelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Garzo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Silani</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient</article-title>
<source/>Stem Cell Res.
          <year>2018</year>
<volume>30</volume>
<fpage>61</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1016/j.scr.2018.05.009</pub-id>
<pub-id pub-id-type="pmid">29800782</pub-id>
</element-citation>
</ref>
<ref id="B53-jpm-10-00008">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Maherali</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ahfeldt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimamura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lensch</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hochedlinger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Daley</surname>
<given-names>G.Q.</given-names>
</name>
</person-group>
<article-title>Disease-Specific Induced Pluripotent Stem Cells</article-title>
<source/>Cell
          <year>2008</year>
<volume>134</volume>
<fpage>877</fpage>
<lpage>886</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.07.041</pub-id>
<pub-id pub-id-type="pmid">18691744</pub-id>
</element-citation>
</ref>
<ref id="B54-jpm-10-00008">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bellin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Welling</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Bott-Flügel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dorn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Goedel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Höhnke</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patient-specific induced pluripotent stem-cell models for long-QT syndrome</article-title>
<source/>N. Engl. J. Med.
          <year>2010</year>
<volume>363</volume>
<fpage>1397</fpage>
<lpage>1409</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa0908679</pub-id>
<pub-id pub-id-type="pmid">20660394</pub-id>
</element-citation>
</ref>
<ref id="B55-jpm-10-00008">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rajamohan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dick</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mellor</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Staniforth</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Denning</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation</article-title>
<source/>Eur. Heart J.
          <year>2011</year>
<volume>32</volume>
<fpage>952</fpage>
<lpage>962</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehr073</pub-id>
<pub-id pub-id-type="pmid">21367833</pub-id>
</element-citation>
</ref>
<ref id="B56-jpm-10-00008">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Shim</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy</article-title>
<source/>Eur. Heart J.
          <year>2013</year>
<volume>34</volume>
<fpage>1122</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehs226</pub-id>
<pub-id pub-id-type="pmid">22798562</pub-id>
</element-citation>
</ref>
<ref id="B57-jpm-10-00008">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Sousa Andrade</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Nathanson</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Menck</surname>
<given-names>C.F.M.</given-names>
</name>
<name>
<surname>Muotri</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome</article-title>
<source/>Hum. Mol. Genet.
          <year>2012</year>
<volume>21</volume>
<fpage>3825</fpage>
<lpage>3834</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/dds211</pub-id>
<pub-id pub-id-type="pmid">22661500</pub-id>
</element-citation>
</ref>
<ref id="B58-jpm-10-00008">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hiratsuka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takiguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Osaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kajitani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hoshiya</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hiramatsu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoshino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kazuki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Complete genetic correction of iPS cells from duchenne muscular dystrophy</article-title>
<source/>Mol. Ther.
          <year>2010</year>
<volume>18</volume>
<fpage>386</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="doi">10.1038/mt.2009.274</pub-id>
<pub-id pub-id-type="pmid">19997091</pub-id>
</element-citation>
</ref>
<ref id="B59-jpm-10-00008">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Papapetrou</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Tomishima</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Fasano</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Ganat</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Viale</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs</article-title>
<source/>Nature
          <year>2009</year>
<volume>461</volume>
<fpage>402</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1038/nature08320</pub-id>
<pub-id pub-id-type="pmid">19693009</pub-id>
</element-citation>
</ref>
<ref id="B60-jpm-10-00008">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urbach</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bar-Nur</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Daley</surname>
<given-names>G.Q.</given-names>
</name>
<name>
<surname>Benvenisty</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells</article-title>
<source/>Cell Stem Cell
          <year>2010</year>
<volume>6</volume>
<fpage>407</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2010.04.005</pub-id>
<pub-id pub-id-type="pmid">20452313</pub-id>
</element-citation>
</ref>
<ref id="B61-jpm-10-00008">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kościelska</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hulsizer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Grace</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nacey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Githinji</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McGee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Garcia-Arocena</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Signaling defects in iPSC-derived fragile X premutation neurons</article-title>
<source/>Hum. Mol. Genet.
          <year>2012</year>
<volume>21</volume>
<fpage>3795</fpage>
<lpage>3805</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/dds207</pub-id>
<pub-id pub-id-type="pmid">22641815</pub-id>
</element-citation>
</ref>
<ref id="B62-jpm-10-00008">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camnasio</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carri</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grad</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mariotti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Castucci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rozell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Riso</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Castiglioni</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zuccato</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington’s disease patients demonstrates mutation related enhanced lysosomal activity</article-title>
<source/>Neurobiol. Dis.
          <year>2012</year>
<volume>46</volume>
<fpage>41</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2011.12.042</pub-id>
<pub-id pub-id-type="pmid">22405424</pub-id>
</element-citation>
</ref>
<ref id="B63-jpm-10-00008">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shim</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuronal properties, in vivo effects, and pathology of a Huntington’s disease patient-derived induced pluripotent stem cells</article-title>
<source/>Stem Cells
          <year>2012</year>
<volume>30</volume>
<fpage>2054</fpage>
<lpage>2062</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1135</pub-id>
<pub-id pub-id-type="pmid">22628015</pub-id>
</element-citation>
</ref>
<ref id="B64-jpm-10-00008">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Montoro</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ellerby</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Characterization of human Huntington’s disease cell model from induced pluripotent stem cells</article-title>
<source/>PLoS Curr.
          <year>2010</year>
<volume>2010</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1371/currents.RRN1193</pub-id>
</element-citation>
</ref>
<ref id="B65-jpm-10-00008">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvajal-Vergara</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sevilla</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dsouza</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>Y.S.</given-names>
</name>
<name>
<surname>Schaniel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Rozov</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome</article-title>
<source/>Nature
          <year>2010</year>
<volume>465</volume>
<fpage>808</fpage>
<lpage>812</lpage>
<pub-id pub-id-type="doi">10.1038/nature09005</pub-id>
<pub-id pub-id-type="pmid">20535210</pub-id>
</element-citation>
</ref>
<ref id="B66-jpm-10-00008">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Breuer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Peitz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jungverdorben</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kesavan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Poppe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Doerr</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ladewig</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tüting</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease</article-title>
<source/>Nature
          <year>2011</year>
<volume>480</volume>
<fpage>543</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.1038/nature10671</pub-id>
<pub-id pub-id-type="pmid">22113611</pub-id>
</element-citation>
</ref>
<ref id="B67-jpm-10-00008">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Andrabi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guardia-laguarta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sundberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mclean</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Carrillo-reid</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hargus</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Deleidi</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Familial Parkinson’s disease iPSCs show cellular deficits in mitochondrial responses that can be pharmacologically rescued</article-title>
<source/>Sci. Transl. Med.
          <year>2012</year>
<volume>4</volume>
<fpage>ra90</fpage>
<lpage>ra141</lpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3003985</pub-id>
<pub-id pub-id-type="pmid">22764206</pub-id>
</element-citation>
</ref>
<ref id="B68-jpm-10-00008">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Hwu</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.T.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification</article-title>
<source/>Hum. Mol. Genet.
          <year>2011</year>
<volume>20</volume>
<fpage>4851</fpage>
<lpage>4864</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr424</pub-id>
<pub-id pub-id-type="pmid">21926084</pub-id>
</element-citation>
</ref>
<ref id="B69-jpm-10-00008">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchetto</surname>
<given-names>M.C.N.</given-names>
</name>
<name>
<surname>Carromeu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Acab</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>F.H.</given-names>
</name>
<name>
<surname>Muotri</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>A model for neural development and treatment of rett syndrome using human induced pluripotent stem cells</article-title>
<source/>Cell
          <year>2010</year>
<volume>143</volume>
<fpage>527</fpage>
<lpage>539</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.10.016</pub-id>
<pub-id pub-id-type="pmid">21074045</pub-id>
</element-citation>
</ref>
<ref id="B70-jpm-10-00008">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ananiev</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from rett syndrome patients as In Vitro disease model</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e25255</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025255</pub-id>
<pub-id pub-id-type="pmid">21966470</pub-id>
</element-citation>
</ref>
<ref id="B71-jpm-10-00008">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheung</surname>
<given-names>A.Y.L.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Grafodatskaya</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pasceri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Weksberg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hotta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carrel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation</article-title>
<source/>Hum. Mol. Genet.
          <year>2011</year>
<volume>20</volume>
<fpage>2103</fpage>
<lpage>2115</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr093</pub-id>
<pub-id pub-id-type="pmid">21372149</pub-id>
</element-citation>
</ref>
<ref id="B72-jpm-10-00008">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamberlain</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Bourgois-Rocha</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lemtiri-Chlieh</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Lalande</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>17668</fpage>
<lpage>17673</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1004487107</pub-id>
<pub-id pub-id-type="pmid">20876107</pub-id>
</element-citation>
</ref>
<ref id="B73-jpm-10-00008">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome</article-title>
<source/>J. Biol. Chem.
          <year>2010</year>
<volume>285</volume>
<fpage>40303</fpage>
<lpage>40311</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.183392</pub-id>
<pub-id pub-id-type="pmid">20956530</pub-id>
</element-citation>
</ref>
<ref id="B74-jpm-10-00008">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brennand</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Simone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gelboin-Burkhart</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sangar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modelling schizophrenia using human induced pluripotent stem cells</article-title>
<source/>Nature
          <year>2011</year>
<volume>473</volume>
<fpage>221</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1038/nature09915</pub-id>
<pub-id pub-id-type="pmid">21490598</pub-id>
</element-citation>
</ref>
<ref id="B75-jpm-10-00008">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silveira Paulsen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>de Moraes Maciel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Galina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>da Silveira</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>dos Santos Souza</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pozzatto</surname>
<given-names>E.N.</given-names>
</name>
<name>
<surname>Junior</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Chicaybam</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Massuda</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient</article-title>
<source/>Cell Transplant.
          <year>2012</year>
<volume>21</volume>
<fpage>1547</fpage>
<lpage>1559</lpage>
<pub-id pub-id-type="pmid">21975034</pub-id>
</element-citation>
</ref>
<ref id="B76-jpm-10-00008">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebert</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>F.F.</given-names>
</name>
<name>
<surname>Mattis</surname>
<given-names>V.B.</given-names>
</name>
<name>
<surname>Lorson</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Svendsen</surname>
<given-names>C.N.</given-names>
</name>
</person-group>
<article-title>Induced pluripotent stem cells from a spinal muscular atrophy patient</article-title>
<source/>Nature
          <year>2009</year>
<volume>457</volume>
<fpage>277</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1038/nature07677</pub-id>
<pub-id pub-id-type="pmid">19098894</pub-id>
</element-citation>
</ref>
<ref id="B77-jpm-10-00008">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yazawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hsueh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Pasca</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Hallmayer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dolmetsch</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome</article-title>
<source/>Nature
          <year>2011</year>
<volume>471</volume>
<fpage>230</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1038/nature09855</pub-id>
<pub-id pub-id-type="pmid">21307850</pub-id>
</element-citation>
</ref>
<ref id="B78-jpm-10-00008">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paşca</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Portmann</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Voineagu</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yazawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shcheglovitov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paşca</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Cord</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Chikahisa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nishino</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome</article-title>
<source/>Nat. Med.
          <year>2011</year>
<volume>17</volume>
<fpage>1657</fpage>
<lpage>1662</lpage>
<pub-id pub-id-type="doi">10.1038/nm.2576</pub-id>
<pub-id pub-id-type="pmid">22120178</pub-id>
</element-citation>
</ref>
<ref id="B79-jpm-10-00008">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arjmand</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Goodarzi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mohamadi-Jahani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Falahzadeh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Larijani</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Personalized regenerative medicine</article-title>
<source/>Acta Med. Iran.
          <year>2017</year>
<volume>55</volume>
<fpage>144</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="pmid">28282715</pub-id>
</element-citation>
</ref>
<ref id="B80-jpm-10-00008">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biffi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Montini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lorioli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cesani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fumagalli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Plati</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Baldoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Calabria</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Canale</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy</article-title>
<source/>Science
          <year>2013</year>
<volume>341</volume>
<fpage>1233158</fpage>
<pub-id pub-id-type="doi">10.1126/science.1233158</pub-id>
<pub-id pub-id-type="pmid">23845948</pub-id>
</element-citation>
</ref>
<ref id="B81-jpm-10-00008">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sessa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lorioli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fumagalli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Acquati</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Redaelli</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Baldoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Canale</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>I.D.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Calabria</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: An ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial</article-title>
<source/>Lancet (Lond. Engl.)
          <year>2016</year>
<volume>388</volume>
<fpage>476</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(16)30374-9</pub-id>
</element-citation>
</ref>
<ref id="B82-jpm-10-00008">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Consiglio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Quattrini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bensadoun</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Dolcetta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Trojani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Benaglia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Marchesini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cestari</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Oliverio</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: Correction of neuropathology and protection against learning impairments in affected mice</article-title>
<source/>Nat. Med.
          <year>2001</year>
<volume>7</volume>
<fpage>310</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1038/85454</pub-id>
<pub-id pub-id-type="pmid">11231629</pub-id>
</element-citation>
</ref>
<ref id="B83-jpm-10-00008">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marconi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tancini</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dolcetta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Angelis</surname>
<given-names>M.G.C.</given-names>
</name>
<name>
<surname>Montanucci</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bregola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sandhoff</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bordignon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease</article-title>
<source/>Hum. Mol. Genet.
          <year>2005</year>
<volume>14</volume>
<fpage>2113</fpage>
<lpage>2123</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddi216</pub-id>
<pub-id pub-id-type="pmid">15961412</pub-id>
</element-citation>
</ref>
<ref id="B84-jpm-10-00008">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ricca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Di Girolamo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Alcala’-Franco</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cavazzin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Orlacchio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Naldini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gritti</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy</article-title>
<source/>Stem Cells
          <year>2011</year>
<volume>29</volume>
<fpage>1559</fpage>
<lpage>1571</lpage>
<pub-id pub-id-type="doi">10.1002/stem.701</pub-id>
<pub-id pub-id-type="pmid">21809420</pub-id>
</element-citation>
</ref>
<ref id="B85-jpm-10-00008">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spronck</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Brouwers</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Vallès</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Haan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Petry</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>van Deventer</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Konstantinova</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Evers</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models</article-title>
<source/>Mol. Ther. Methods Clin. Dev.
          <year>2019</year>
<volume>13</volume>
<fpage>334</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1016/j.omtm.2019.03.002</pub-id>
<pub-id pub-id-type="pmid">30984798</pub-id>
</element-citation>
</ref>
<ref id="B86-jpm-10-00008">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nayerossadat</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maedeh</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Viral and nonviral delivery systems for gene delivery</article-title>
<source/>Adv. Biomed. Res.
          <year>2012</year>
<volume>1</volume>
<fpage>27</fpage>
<pub-id pub-id-type="doi">10.4103/2277-9175.98152</pub-id>
<pub-id pub-id-type="pmid">23210086</pub-id>
</element-citation>
</ref>
<ref id="B87-jpm-10-00008">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Markusic</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>High</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Herzog</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Clinical development of gene therapy: Results and lessons from recent successes</article-title>
<source/>Mol. Ther. Methods Clin. Dev.
          <year>2016</year>
<volume>3</volume>
<fpage>16034</fpage>
<pub-id pub-id-type="doi">10.1038/mtm.2016.34</pub-id>
<pub-id pub-id-type="pmid">27257611</pub-id>
</element-citation>
</ref>
<ref id="B88-jpm-10-00008">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunbar</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>High</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Joung</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Kohn</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Ozawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sadelain</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Gene therapy comes of age</article-title>
<source/>Science
          <year>2018</year>
<volume>359</volume>
<fpage>eaan4672</fpage>
<pub-id pub-id-type="doi">10.1126/science.aan4672</pub-id>
<pub-id pub-id-type="pmid">29326244</pub-id>
</element-citation>
</ref>
<ref id="B89-jpm-10-00008">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahryari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jazi</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nikoo</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Nazari</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hosseini</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Burtscher</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mowla</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Lickert</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Development and clinical translation of approved gene therapy products for genetic disorders</article-title>
<source/>Front. Genet.
          <year>2019</year>
<volume>10</volume>
<fpage>868</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.00868</pub-id>
<pub-id pub-id-type="pmid">31608113</pub-id>
</element-citation>
</ref>
<ref id="B90-jpm-10-00008">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gopinath</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nathar</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hickstein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Remington Nelson</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Contemporary Animal Models For Human Gene Therapy Applications</article-title>
<source/>Curr. Gene Ther.
          <year>2015</year>
<volume>15</volume>
<fpage>531</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.2174/1566523215666150929110424</pub-id>
<pub-id pub-id-type="pmid">26415576</pub-id>
</element-citation>
</ref>
<ref id="B91-jpm-10-00008">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elverum</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Whitman</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Delivering cellular and gene therapies to patients: Solutions for realizing the potential of the next generation of medicine</article-title>
<source/>Gene Ther.
          <year>2019</year>
<volume>2019</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/s41434-019-0074-7</pub-id>
</element-citation>
</ref>
<ref id="B92-jpm-10-00008">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ornaghi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sala</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tedeschi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Maffia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Bazzucchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Valsecchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aureli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gritti</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: Implications for in vivo end ex vivo gene therapy of GM2 gangliosidosis</article-title>
<source/>Neurobiol. Dis.
          <year>2019</year>
<volume>2019</volume>
<fpage>104667</fpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2019.104667</pub-id>
</element-citation>
</ref>
<ref id="B93-jpm-10-00008">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ungari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Montepeloso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cocchiarella</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Recchia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gentner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Naldini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Biffi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy</article-title>
<source/>Mol. Ther. Methods Clin. Dev.
          <year>2015</year>
<volume>2</volume>
<fpage>15038</fpage>
<pub-id pub-id-type="doi">10.1038/mtm.2015.38</pub-id>
<pub-id pub-id-type="pmid">26509184</pub-id>
</element-citation>
</ref>
<ref id="B94-jpm-10-00008">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dolcetta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cusella De Angelis</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Chigorno</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Severini</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Sandhoff</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bordignon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sonnino</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model</article-title>
<source/>Neurochem. Res.
          <year>2002</year>
<volume>27</volume>
<fpage>793</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="doi">10.1023/A:1020256924099</pub-id>
<pub-id pub-id-type="pmid">12374215</pub-id>
</element-citation>
</ref>
<ref id="B95-jpm-10-00008">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tancini</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Severini</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Chigorno</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bordignon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sonnino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Orlacchio</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Absence of Metabolic Cross-correction in Tay-Sachs Cells</article-title>
<source/>J. Biol. Chem.
          <year>2002</year>
<volume>277</volume>
<fpage>20177</fpage>
<lpage>20184</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M106164200</pub-id>
<pub-id pub-id-type="pmid">11923278</pub-id>
</element-citation>
</ref>
<ref id="B96-jpm-10-00008">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meneghini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lattanzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tiradani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bravo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sanvito</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Calabria</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bringas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fisher-Perkins</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Dufour</surname>
<given-names>J.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy</article-title>
<source/>EMBO Mol. Med.
          <year>2016</year>
<volume>8</volume>
<fpage>489</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.15252/emmm.201505850</pub-id>
<pub-id pub-id-type="pmid">27025653</pub-id>
</element-citation>
</ref>
<ref id="B97-jpm-10-00008">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aiuti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Roncarolo</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Naldini</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: Paving the road for the next generation of advanced therapy medicinal products</article-title>
<source/>EMBO Mol. Med.
          <year>2017</year>
<volume>9</volume>
<fpage>737</fpage>
<lpage>740</lpage>
<pub-id pub-id-type="doi">10.15252/emmm.201707573</pub-id>
<pub-id pub-id-type="pmid">28396566</pub-id>
</element-citation>
</ref>
<ref id="B98-jpm-10-00008">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakthiswary</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Stem cell therapy in neurodegenerative diseases: From principles to practice</article-title>
<source/>Neural Regen. Res.
          <year>2012</year>
<volume>7</volume>
<fpage>1822</fpage>
<pub-id pub-id-type="pmid">25624807</pub-id>
</element-citation>
</ref>
<ref id="B99-jpm-10-00008">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goswami</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Silayeva</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Newkirk</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Doctor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chawla</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chattopadhyay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chilukuri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Betapudi</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Gene therapy leaves a vicious cycle</article-title>
<source/>Front. Oncol.
          <year>2019</year>
<volume>9</volume>
<fpage>297</fpage>
<pub-id pub-id-type="doi">10.3389/fonc.2019.00297</pub-id>
<pub-id pub-id-type="pmid">31069169</pub-id>
</element-citation>
</ref>
<ref id="B100-jpm-10-00008">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9</article-title>
<source/>Mol. Ther.
          <year>2019</year>
<volume>27</volume>
<fpage>735</fpage>
<lpage>746</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymthe.2019.01.014</pub-id>
<pub-id pub-id-type="pmid">30803822</pub-id>
</element-citation>
</ref>
<ref id="B101-jpm-10-00008">
<label>101.</label>
<element-citation publication-type="web">
<article-title>Gene-Editing Could Modify and Cure Disease: CRISPR vs. TALENs</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://ark-invest.com/research/crispr-vs-talens">https://ark-invest.com/research/crispr-vs-talens</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-12-04">(accessed on 4 December 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B102-jpm-10-00008">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Razzouk</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>CRISPR-Cas9: A cornerstone for the evolution of precision medicine</article-title>
<source/>Ann. Hum. Genet.
          <year>2018</year>
<volume>82</volume>
<fpage>331</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1111/ahg.12271</pub-id>
<pub-id pub-id-type="pmid">30014471</pub-id>
</element-citation>
</ref>
<ref id="B103-jpm-10-00008">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knott</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Doudna</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>CRISPR-Cas guides the future of genetic engineering</article-title>
<source/>Science
          <year>2018</year>
<volume>361</volume>
<fpage>866</fpage>
<lpage>869</lpage>
<pub-id pub-id-type="doi">10.1126/science.aat5011</pub-id>
<pub-id pub-id-type="pmid">30166482</pub-id>
</element-citation>
</ref>
<ref id="B104-jpm-10-00008">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jinek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chylinski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fonfara</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hauer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Doudna</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Charpentier</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity</article-title>
<source/>Science
          <year>2012</year>
<volume>337</volume>
<fpage>816</fpage>
<lpage>821</lpage>
<pub-id pub-id-type="doi">10.1126/science.1225829</pub-id>
<pub-id pub-id-type="pmid">22745249</pub-id>
</element-citation>
</ref>
<ref id="B105-jpm-10-00008">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anders</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Niewoehner</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Duerst</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jinek</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease</article-title>
<source/>Nature
          <year>2014</year>
<volume>513</volume>
<fpage>569</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="doi">10.1038/nature13579</pub-id>
<pub-id pub-id-type="pmid">25079318</pub-id>
</element-citation>
</ref>
<ref id="B106-jpm-10-00008">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rath</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Amlinger</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rath</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lundgren</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The CRISPR-Cas immune system: Biology, mechanisms and applications</article-title>
<source/>Biochimie
          <year>2015</year>
<volume>117</volume>
<fpage>119</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1016/j.biochi.2015.03.025</pub-id>
<pub-id pub-id-type="pmid">25868999</pub-id>
</element-citation>
</ref>
<ref id="B107-jpm-10-00008">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aach</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mali</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>G.M.</given-names>
</name>
</person-group>
<article-title>CasFinder: Flexible Algorithm for Identifying Specific Cas9 Targets in Genomes</article-title>
<source/>bioRxiv
          <year>2014</year>
<fpage>005074</fpage>
</element-citation>
</ref>
<ref id="B108-jpm-10-00008">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montague</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Gagnon</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Valen</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>CHOPCHOP: A CRISPR/Cas9 and TALEN web tool for genome editing</article-title>
<source/>Nucleic Acids Res.
          <year>2014</year>
<volume>42</volume>
<fpage>W401</fpage>
<lpage>W407</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gku410</pub-id>
<pub-id pub-id-type="pmid">24861617</pub-id>
</element-citation>
</ref>
<ref id="B109-jpm-10-00008">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Dominguez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>CRISPR-ERA: A comprehensive design tool for CRISPR-mediated gene editing, repression and activation</article-title>
<source/>Bioinformatics
          <year>2015</year>
<volume>31</volume>
<fpage>3676</fpage>
<lpage>3678</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btv423</pub-id>
<pub-id pub-id-type="pmid">26209430</pub-id>
</element-citation>
</ref>
<ref id="B110-jpm-10-00008">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Köster</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CRISPR-DO for genome-wide CRISPR design and optimization</article-title>
<source/>Bioinformatics
          <year>2016</year>
<volume>32</volume>
<fpage>3336</fpage>
<lpage>3338</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btw476</pub-id>
<pub-id pub-id-type="pmid">27402906</pub-id>
</element-citation>
</ref>
<ref id="B111-jpm-10-00008">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Pritykin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vidigal</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Chhangawala</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zamparo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>GuideScan software for improved single and paired CRISPR guide RNA design</article-title>
<source/>Nat. Biotechnol.
          <year>2017</year>
<volume>35</volume>
<fpage>347</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.3804</pub-id>
<pub-id pub-id-type="pmid">28263296</pub-id>
</element-citation>
</ref>
<ref id="B112-jpm-10-00008">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sunagawa</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Sumiyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ukai-Tadenuma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perrin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fujishima</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ukai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>R.I.</given-names>
</name>
<name>
<surname>Narumi</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mammalian Reverse Genetics without Crossing Reveals Nr3a as a Short-Sleeper Gene</article-title>
<source/>Cell Rep.
          <year>2016</year>
<volume>14</volume>
<fpage>662</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.052</pub-id>
<pub-id pub-id-type="pmid">26774482</pub-id>
</element-citation>
</ref>
<ref id="B113-jpm-10-00008">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Armentano</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Montanucci</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Argentati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fortunati</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Montesano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bicchi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pescara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pennoni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mattioli</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Design of a nanocomposite substrate inducing adult stem cell assembly and progression toward an Epiblast-like or Primitive Endoderm-like phenotype via mechanotransduction</article-title>
<source/>Biomaterials
          <year>2017</year>
<volume>144</volume>
<fpage>211</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.08.015</pub-id>
<pub-id pub-id-type="pmid">28841465</pub-id>
</element-citation>
</ref>
<ref id="B114-jpm-10-00008">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caplan</surname>
<given-names>A.I.</given-names>
</name>
</person-group>
<article-title>Tissue Engineering: Then, Now, and the Future</article-title>
<source/>Tissue Eng. Part A
          <year>2019</year>
<volume>25</volume>
<fpage>515</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1089/ten.tea.2019.0011</pub-id>
<pub-id pub-id-type="pmid">30654728</pub-id>
</element-citation>
</ref>
<ref id="B115-jpm-10-00008">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Challenges With the Development of Biomaterials for Sustainable Tissue Engineering</article-title>
<source/>Front. Bioeng. Biotechnol.
          <year>2019</year>
<volume>7</volume>
<fpage>127</fpage>
<pub-id pub-id-type="doi">10.3389/fbioe.2019.00127</pub-id>
<pub-id pub-id-type="pmid">31214584</pub-id>
</element-citation>
</ref>
<ref id="B116-jpm-10-00008">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argentati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Montanucci</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rallini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Basta</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Calafiore</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cordellini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Armentano</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Surface hydrophilicity of poly(L-lactide) acid polymer film changes the human adult adipose stem cell architecture</article-title>
<source/>Polymers
          <year>2018</year>
<volume>10</volume>
<elocation-id>140</elocation-id>
<pub-id pub-id-type="doi">10.3390/polym10020140</pub-id>
</element-citation>
</ref>
<ref id="B117-jpm-10-00008">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Advancing biomaterials of human origin for tissue engineering</article-title>
<source/>Prog. Polym. Sci.
          <year>2016</year>
<volume>53</volume>
<fpage>86</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1016/j.progpolymsci.2015.02.004</pub-id>
<pub-id pub-id-type="pmid">27022202</pub-id>
</element-citation>
</ref>
<ref id="B118-jpm-10-00008">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Argentati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Calzoni</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cordellini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>D’Angelo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Ex-vivo tissues engineering modeling for reconstructive surgery using human adult adipose stem cells and polymeric nanostructured matrix</article-title>
<source/>Nanomaterials
          <year>2016</year>
<volume>6</volume>
<elocation-id>57</elocation-id>
<pub-id pub-id-type="doi">10.3390/nano6040057</pub-id>
<pub-id pub-id-type="pmid">28335186</pub-id>
</element-citation>
</ref>
<ref id="B119-jpm-10-00008">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarpani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gambucci</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zampini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Massaro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Argentati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Emiliani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Latterini</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The influence of modified silica nanomaterials on adult stem cell culture</article-title>
<source/>Nanomaterials
          <year>2016</year>
<volume>6</volume>
<elocation-id>104</elocation-id>
<pub-id pub-id-type="doi">10.3390/nano6060104</pub-id>
</element-citation>
</ref>
<ref id="B120-jpm-10-00008">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mani</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Jaganathan</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Md Khudzari</surname>
<given-names>A.Z.</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Green synthesis of nickel oxide particles and its integration into polyurethane scaffold matrix ornamented with groundnut oil for bone tissue engineering</article-title>
<source/>Int. J. Polym. Anal. Charact.
          <year>2019</year>
<volume>24</volume>
<fpage>571</fpage>
<lpage>583</lpage>
<pub-id pub-id-type="doi">10.1080/1023666X.2019.1630930</pub-id>
</element-citation>
</ref>
<ref id="B121-jpm-10-00008">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayoun-Neeman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Korover</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Etzion</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ofir</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lichtenstein</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Exploring peptide-functionalized alginate scaffolds for engineering cardiac tissue from human embryonic stem cell-derived cardiomyocytes in serum-free medium</article-title>
<source/>Polym. Adv. Technol.
          <year>2019</year>
<volume>30</volume>
<fpage>2493</fpage>
<lpage>2505</lpage>
<pub-id pub-id-type="doi">10.1002/pat.4602</pub-id>
</element-citation>
</ref>
<ref id="B122-jpm-10-00008">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armentano</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Puglia</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Luzi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Arciola</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Nanocomposites based on biodegradable polymers</article-title>
<source/>Materials
          <year>2018</year>
<volume>11</volume>
<elocation-id>795</elocation-id>
<pub-id pub-id-type="doi">10.3390/ma11050795</pub-id>
</element-citation>
</ref>
<ref id="B123-jpm-10-00008">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armentano</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tarpani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Morena</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Latterini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Nanostructured Biopolymer-based Materials for Regenerative Medicine Applications</article-title>
<source/>Curr. Org. Chem.
          <year>2018</year>
<volume>22</volume>
<fpage>1193</fpage>
<lpage>1204</lpage>
<pub-id pub-id-type="doi">10.2174/1385272822666180517095551</pub-id>
</element-citation>
</ref>
<ref id="B124-jpm-10-00008">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jansen</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Donato</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Balcioglu</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Danen</surname>
<given-names>E.H.J.</given-names>
</name>
<name>
<surname>Koenderink</surname>
<given-names>G.H.</given-names>
</name>
</person-group>
<article-title>A guide to mechanobiology: Where biology and physics meet</article-title>
<source/>Biochim. Biophys. Acta Mol. Cell Res.
          <year>2015</year>
<volume>1853</volume>
<fpage>3043</fpage>
<lpage>3052</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2015.05.007</pub-id>
</element-citation>
</ref>
<ref id="B125-jpm-10-00008">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguado</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Grim</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Rosales</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Watson-Capps</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Anseth</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>Engineering precision biomaterials for personalized medicine</article-title>
<source/>Sci. Transl. Med.
          <year>2018</year>
<volume>10</volume>
<fpage>eaam8645</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.aam8645</pub-id>
<pub-id pub-id-type="pmid">29343626</pub-id>
</element-citation>
</ref>
<ref id="B126-jpm-10-00008">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abou-El-Enein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Elsanhoury</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Reinke</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Overcoming Challenges Facing Advanced Therapies in the EU Market</article-title>
<source/>Cell Stem Cell
          <year>2016</year>
<volume>19</volume>
<fpage>293</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2016.08.012</pub-id>
<pub-id pub-id-type="pmid">27588746</pub-id>
</element-citation>
</ref>
<ref id="B127-jpm-10-00008">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hart</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Loewen-Rodriguez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lessem</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Dermagraft: Use in the Treatment of Chronic Wounds</article-title>
<source/>Adv. Wound Care
          <year>2012</year>
<volume>1</volume>
<fpage>138</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1089/wound.2011.0282</pub-id>
<pub-id pub-id-type="pmid">24527294</pub-id>
</element-citation>
</ref>
<ref id="B128-jpm-10-00008">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kreuz</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Kalkreuth</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Niemeyer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Uhl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Erggelet</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Long-Term Clinical and MRI Results of Matrix-Assisted Autologous Chondrocyte Implantation for Articular Cartilage Defects of the Knee</article-title>
<source/>Cartilage
          <year>2019</year>
<volume>10</volume>
<fpage>305</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1177/1947603518756463</pub-id>
<pub-id pub-id-type="pmid">29429373</pub-id>
</element-citation>
</ref>
<ref id="B129-jpm-10-00008">
<label>129.</label>
<element-citation publication-type="gov">
<article-title>Epicel (cultured epidermal autografts) | FDA</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/epicel-cultured-epidermal-autografts">https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/epicel-cultured-epidermal-autografts</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-12-02">(accessed on 2 December 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B130-jpm-10-00008">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varkey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tredget</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Advances in Skin Substitutes—Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing</article-title>
<source/>J. Funct. Biomater.
          <year>2015</year>
<volume>6</volume>
<fpage>547</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.3390/jfb6030547</pub-id>
<pub-id pub-id-type="pmid">26184327</pub-id>
</element-citation>
</ref>
<ref id="B131-jpm-10-00008">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pellegrini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ardigò</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Milazzo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Iotti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Guatelli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pelosi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union</article-title>
<source/>Stem Cells Transl. Med.
          <year>2018</year>
<volume>7</volume>
<fpage>146</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1002/sctm.17-0003</pub-id>
<pub-id pub-id-type="pmid">29280318</pub-id>
</element-citation>
</ref>
<ref id="B132-jpm-10-00008">
<label>132.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Berkowitz</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Ferkel</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>New and emerging techniques in cartilage repair: Matrix-induced autologous chondrocyte implantation (MACI)</article-title>
<source/>Sports Injuries of the Foot and Ankle: A Focus on Advanced Surgical Techniques
          <publisher-name>Springer</publisher-name>
<publisher-loc>Berlin/Heidelberg, Germany</publisher-loc>
<year>2019</year>
<fpage>125</fpage>
<lpage>131</lpage>
<isbn>9783662587041</isbn>
</element-citation>
</ref>
<ref id="B133-jpm-10-00008">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoburg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Löer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Körsmeier</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Siebold</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Niemeyer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fickert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ruhnau</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Matrix-Associated Autologous Chondrocyte Implantation Is an Effective Treatment at Midterm Follow-up in Adolescents and Young Adults</article-title>
<source/>Orthop. J. Sports Med.
          <year>2019</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.1177/2325967119841077</pub-id>
</element-citation>
</ref>
<ref id="B134-jpm-10-00008">
<label>134.</label>
<element-citation publication-type="web">
<article-title>Spherox | European Medicines Agency</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/medicines/human/EPAR/spherox">https://www.ema.europa.eu/en/medicines/human/EPAR/spherox</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-12-02">(accessed on 2 December 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B135-jpm-10-00008">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Atala</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>3D bioprinting of tissues and organs</article-title>
<source/>Nat. Biotechnol.
          <year>2014</year>
<volume>32</volume>
<fpage>773</fpage>
<lpage>785</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.2958</pub-id>
<pub-id pub-id-type="pmid">25093879</pub-id>
</element-citation>
</ref>
<ref id="B136-jpm-10-00008">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jammalamadaka</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Tappa</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Recent advances in biomaterials for 3D printing and tissue engineering</article-title>
<source/>J. Funct. Biomater.
          <year>2018</year>
<volume>9</volume>
<elocation-id>22</elocation-id>
<pub-id pub-id-type="doi">10.3390/jfb9010022</pub-id>
<pub-id pub-id-type="pmid">29494503</pub-id>
</element-citation>
</ref>
<ref id="B137-jpm-10-00008">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.G.</given-names>
</name>
</person-group>
<article-title>Biologically Inspired Smart Release System Based on 3D Bioprinted Perfused Scaffold for Vascularized Tissue Regeneration</article-title>
<source/>Adv. Sci.
          <year>2016</year>
<volume>3</volume>
<fpage>1600058</fpage>
<pub-id pub-id-type="doi">10.1002/advs.201600058</pub-id>
</element-citation>
</ref>
<ref id="B138-jpm-10-00008">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albritton</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>3D bioprinting: Improving in vitro models of metastasis with heterogeneous tumor microenvironments</article-title>
<source/>DMM Dis. Model. Mech.
          <year>2017</year>
<volume>10</volume>
<fpage>3</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1242/dmm.025049</pub-id>
<pub-id pub-id-type="pmid">28067628</pub-id>
</element-citation>
</ref>
<ref id="B139-jpm-10-00008">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Celli</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rizvi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Demirci</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform</article-title>
<source/>Biotechnol. J.
          <year>2011</year>
<volume>6</volume>
<fpage>204</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1002/biot.201000340</pub-id>
<pub-id pub-id-type="pmid">21298805</pub-id>
</element-citation>
</ref>
<ref id="B140-jpm-10-00008">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling</article-title>
<source/>Adv. Drug Deliv. Rev.
          <year>2018</year>
<volume>132</volume>
<fpage>235</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.addr.2018.06.011</pub-id>
<pub-id pub-id-type="pmid">29935988</pub-id>
</element-citation>
</ref>
<ref id="B141-jpm-10-00008">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>De Coppi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Atala</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Opportunities and challenges of translational 3D bioprinting</article-title>
<source/>Nat. Biomed. Eng.
          <year>2019</year>
<volume>2019</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1038/s41551-019-0471-7</pub-id>
<pub-id pub-id-type="pmid">31695178</pub-id>
</element-citation>
</ref>
<ref id="B142-jpm-10-00008">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lancaster</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Huch</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Disease modelling in human organoids</article-title>
<source/>DMM Dis. Model. Mech.
          <year>2019</year>
<volume>12</volume>
<fpage>dmm039347</fpage>
<pub-id pub-id-type="doi">10.1242/dmm.039347</pub-id>
<pub-id pub-id-type="pmid">31383635</pub-id>
</element-citation>
</ref>
<ref id="B143-jpm-10-00008">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Organoids have opened avenues into investigating numerous diseases. But how well do they mimic the real thing?</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>3507</fpage>
<lpage>3509</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1803647115</pub-id>
<pub-id pub-id-type="pmid">29615533</pub-id>
</element-citation>
</ref>
<ref id="B144-jpm-10-00008">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Organoids for Drug Discovery and Personalized Medicine</article-title>
<source/>Annu. Rev. Pharmacol. Toxicol.
          <year>2019</year>
<volume>59</volume>
<fpage>447</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-pharmtox-010818-021108</pub-id>
<pub-id pub-id-type="pmid">30113875</pub-id>
</element-citation>
</ref>
<ref id="B145-jpm-10-00008">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehmann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Shugart</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Charo</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Gartner</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Human organoids: A new dimension in cell biology</article-title>
<source/>Mol. Biol. Cell
          <year>2019</year>
<volume>30</volume>
<fpage>1129</fpage>
<lpage>1137</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.E19-03-0135</pub-id>
<pub-id pub-id-type="pmid">31034354</pub-id>
</element-citation>
</ref>
<ref id="B146-jpm-10-00008">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vries</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Snippert</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Van De Wetering</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Stange</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Van Es</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Abo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kujala</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>P.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche</article-title>
<source/>Nature
          <year>2009</year>
<volume>459</volume>
<fpage>262</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1038/nature07935</pub-id>
<pub-id pub-id-type="pmid">19329995</pub-id>
</element-citation>
</ref>
<ref id="B147-jpm-10-00008">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hunziker</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Choudhury</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Engineering microfluidic organoid-on-a-chip platforms</article-title>
<source/>Micromachines
          <year>2019</year>
<volume>10</volume>
<elocation-id>165</elocation-id>
<pub-id pub-id-type="doi">10.3390/mi10030165</pub-id>
</element-citation>
</ref>
<ref id="B148-jpm-10-00008">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brassard</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Lutolf</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Engineering Stem Cell Self-organization to Build Better Organoids</article-title>
<source/>Cell Stem Cell
          <year>2019</year>
<volume>24</volume>
<fpage>860</fpage>
<lpage>876</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2019.05.005</pub-id>
<pub-id pub-id-type="pmid">31173716</pub-id>
</element-citation>
</ref>
<ref id="B149-jpm-10-00008">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaushik</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ponnusamy</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models</article-title>
<source/>Stem Cells
          <year>2018</year>
<volume>36</volume>
<fpage>1329</fpage>
<lpage>1340</lpage>
<pub-id pub-id-type="doi">10.1002/stem.2852</pub-id>
<pub-id pub-id-type="pmid">29770526</pub-id>
</element-citation>
</ref>
<ref id="B150-jpm-10-00008">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Matulay</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Owczarek</surname>
<given-names>T.B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Barlow</surname>
<given-names>L.M.J.</given-names>
</name>
<name>
<surname>Kandoth</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>A.B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer</article-title>
<source/>Cell
          <year>2018</year>
<volume>173</volume>
<fpage>515</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2018.03.017</pub-id>
<pub-id pub-id-type="pmid">29625057</pub-id>
</element-citation>
</ref>
<ref id="B151-jpm-10-00008">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullenders</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>de Jongh</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brousali</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Roosen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blom</surname>
<given-names>J.P.A.</given-names>
</name>
<name>
<surname>Begthel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Korving</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jonges</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kranenburg</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Meijer</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mouse and human urothelial cancer organoids: A tool for bladder cancer research</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2019</year>
<volume>116</volume>
<fpage>4567</fpage>
<lpage>4574</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1803595116</pub-id>
<pub-id pub-id-type="pmid">30787188</pub-id>
</element-citation>
</ref>
<ref id="B152-jpm-10-00008">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wimmer</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Leopoldi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aichinger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wick</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hantusch</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Novatchkova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taubenschmid</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hämmerle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Esk</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bagley</surname>
<given-names>J.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human blood vessel organoids as a model of diabetic vasculopathy</article-title>
<source/>Nature
          <year>2019</year>
<volume>565</volume>
<fpage>505</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-018-0858-8</pub-id>
<pub-id pub-id-type="pmid">30651639</pub-id>
</element-citation>
</ref>
<ref id="B153-jpm-10-00008">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lancaster</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Wenzel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bicknell</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Hurles</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Homfray</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Penninger</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Cerebral organoids model human brain development and microcephaly</article-title>
<source/>Nature
          <year>2013</year>
<volume>501</volume>
<fpage>373</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1038/nature12517</pub-id>
<pub-id pub-id-type="pmid">23995685</pub-id>
</element-citation>
</ref>
<ref id="B154-jpm-10-00008">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariani</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Abyzov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Provini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tomasini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Amenduni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Szekely</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Palejev</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders</article-title>
<source/>Cell
          <year>2015</year>
<volume>162</volume>
<fpage>375</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.06.034</pub-id>
<pub-id pub-id-type="pmid">26186191</pub-id>
</element-citation>
</ref>
<ref id="B155-jpm-10-00008">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tcw</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kouznetsova</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ogden</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Hammack</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen</article-title>
<source/>Nat. Med.
          <year>2016</year>
<volume>22</volume>
<fpage>1101</fpage>
<lpage>1107</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4184</pub-id>
<pub-id pub-id-type="pmid">27571349</pub-id>
</element-citation>
</ref>
<ref id="B156-jpm-10-00008">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raja</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Mungenast</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Abdurrob</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer’s disease phenotypes</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<elocation-id>e0161969</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0161969</pub-id>
<pub-id pub-id-type="pmid">27622770</pub-id>
</element-citation>
</ref>
<ref id="B157-jpm-10-00008">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moslem</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Olive</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Falk</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Stem cell models of schizophrenia, what have we learned and what is the potential?</article-title>
<source/>Schizophr. Res.
          <year>2019</year>
<volume>210</volume>
<fpage>3</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2018.12.023</pub-id>
<pub-id pub-id-type="pmid">30587427</pub-id>
</element-citation>
</ref>
<ref id="B158-jpm-10-00008">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwamborn</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Is Parkinson’s disease a neurodevelopmental disorder and will brain organoids help us to understand it?</article-title>
<source/>Stem Cells Dev.
          <year>2018</year>
<volume>27</volume>
<fpage>968</fpage>
<lpage>975</lpage>
<pub-id pub-id-type="doi">10.1089/scd.2017.0289</pub-id>
<pub-id pub-id-type="pmid">29415619</pub-id>
</element-citation>
</ref>
<ref id="B159-jpm-10-00008">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bejoy</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kanekiyo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Modeling neurodegenerative microenvironment using cortical organoids derived from human stem cells</article-title>
<source/>Tissue Eng. Part A
          <year>2018</year>
<volume>24</volume>
<fpage>1125</fpage>
<lpage>1137</lpage>
<pub-id pub-id-type="doi">10.1089/ten.tea.2017.0423</pub-id>
<pub-id pub-id-type="pmid">29361890</pub-id>
</element-citation>
</ref>
<ref id="B160-jpm-10-00008">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iefremova</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Manikakis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Krefft</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Jabali</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weynans</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wilkens</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Marsoner</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Brändl</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An Organoid-Based Model of Cortical Development Identifies Non-Cell-Autonomous Defects in Wnt Signaling Contributing to Miller-Dieker Syndrome</article-title>
<source/>Cell Rep.
          <year>2017</year>
<volume>19</volume>
<fpage>50</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.047</pub-id>
<pub-id pub-id-type="pmid">28380362</pub-id>
</element-citation>
</ref>
<ref id="B161-jpm-10-00008">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bershteyn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nowakowski</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Pollen</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Di Lullo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nene</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wynshaw-Boris</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kriegstein</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Human iPSC-Derived Cerebral Organoids Model Cellular Features of Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia</article-title>
<source/>Cell Stem Cell
          <year>2017</year>
<volume>20</volume>
<fpage>435</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2016.12.007</pub-id>
<pub-id pub-id-type="pmid">28111201</pub-id>
</element-citation>
</ref>
<ref id="B162-jpm-10-00008">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hubert</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Spangler</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Prager</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Couce</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McLendon</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>J.N.</given-names>
</name>
</person-group>
<article-title>A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo</article-title>
<source/>Cancer Res.
          <year>2016</year>
<volume>76</volume>
<fpage>2465</fpage>
<lpage>2477</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-2402</pub-id>
<pub-id pub-id-type="pmid">26896279</pub-id>
</element-citation>
</ref>
<ref id="B163-jpm-10-00008">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcez</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Loiola</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Da Costa</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Higa</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Trindade</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Delvecchio</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nascimento</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Brindeiro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tanuri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rehen</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Zika virus: Zika virus impairs growth in human neurospheres and brain organoids</article-title>
<source/>Science
          <year>2016</year>
<volume>352</volume>
<fpage>816</fpage>
<lpage>818</lpage>
<pub-id pub-id-type="doi">10.1126/science.aaf6116</pub-id>
<pub-id pub-id-type="pmid">27064148</pub-id>
</element-citation>
</ref>
<ref id="B164-jpm-10-00008">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cugola</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>I.R.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Freitas</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>J.L.M.</given-names>
</name>
<name>
<surname>Guimarães</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Benazzato</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pignatari</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Brazilian Zika virus strain causes birth defects in experimental models</article-title>
<source/>Nature
          <year>2016</year>
<volume>534</volume>
<fpage>267</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1038/nature18296</pub-id>
<pub-id pub-id-type="pmid">27279226</pub-id>
</element-citation>
</ref>
<ref id="B165-jpm-10-00008">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Hadiono</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ogden</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Hammack</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hamersky</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure</article-title>
<source/>Cell
          <year>2016</year>
<volume>165</volume>
<fpage>1238</fpage>
<lpage>1254</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.04.032</pub-id>
<pub-id pub-id-type="pmid">27118425</pub-id>
</element-citation>
</ref>
<ref id="B166-jpm-10-00008">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Buth</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Vishlaghi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>de la Torre-Ubieta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Taxidis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Khakh</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Yamauchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Self-Organized Cerebral Organoids with Human-Specific Features Predict Effective Drugs to Combat Zika Virus Infection</article-title>
<source/>Cell Rep.
          <year>2017</year>
<volume>21</volume>
<fpage>517</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.047</pub-id>
<pub-id pub-id-type="pmid">29020636</pub-id>
</element-citation>
</ref>
<ref id="B167-jpm-10-00008">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sacramento</surname>
<given-names>C.Q.</given-names>
</name>
<name>
<surname>De Melo</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>De Freitas</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hoelz</surname>
<given-names>L.V.B.</given-names>
</name>
<name>
<surname>Miranda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fintelman-Rodrigues</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Marttorelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Barbosa-Lima</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>40920</fpage>
<pub-id pub-id-type="doi">10.1038/srep40920</pub-id>
<pub-id pub-id-type="pmid">28098253</pub-id>
</element-citation>
</ref>
<ref id="B168-jpm-10-00008">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachs</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>de Ligt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kopper</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gogola</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bounova</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Weeber</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Balgobind</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Wind</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gracanin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Begthel</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity</article-title>
<source/>Cell
          <year>2018</year>
<volume>172</volume>
<fpage>373</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2017.11.010</pub-id>
<pub-id pub-id-type="pmid">29224780</pub-id>
</element-citation>
</ref>
<ref id="B169-jpm-10-00008">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van De Wetering</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Francies</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Bounova</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Iorio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pronk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Houdt</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Van Gorp</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Taylor-Weiner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kester</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prospective derivation of a living organoid biobank of colorectal cancer patients</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<fpage>933</fpage>
<lpage>945</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.03.053</pub-id>
<pub-id pub-id-type="pmid">25957691</pub-id>
</element-citation>
</ref>
<ref id="B170-jpm-10-00008">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turco</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cindrova-Davies</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Farrell</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hollinshead</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>S.G.E.</given-names>
</name>
<name>
<surname>Brosens</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Critchley</surname>
<given-names>H.O.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium</article-title>
<source/>Nat. Cell Biol.
          <year>2017</year>
<volume>19</volume>
<fpage>568</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="doi">10.1038/ncb3516</pub-id>
<pub-id pub-id-type="pmid">28394884</pub-id>
</element-citation>
</ref>
<ref id="B171-jpm-10-00008">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boretto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maenhoudt</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hennes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boeckx</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bui</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Heremans</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Perneel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Van Zundert</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening</article-title>
<source/>Nat. Cell Biol.
          <year>2019</year>
<volume>21</volume>
<fpage>1041</fpage>
<lpage>1051</lpage>
<pub-id pub-id-type="doi">10.1038/s41556-019-0360-z</pub-id>
<pub-id pub-id-type="pmid">31371824</pub-id>
</element-citation>
</ref>
<ref id="B172-jpm-10-00008">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Francies</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Secrier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Miremadi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Galeano-Dalmau</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Barendt</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Letchford</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Leyden</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Goffin</surname>
<given-names>E.K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-05190-9</pub-id>
<pub-id pub-id-type="pmid">29317637</pub-id>
</element-citation>
</ref>
<ref id="B173-jpm-10-00008">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nugraha</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Buono</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>von Boehmer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hoerstrup</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Emmert</surname>
<given-names>M.Y.</given-names>
</name>
</person-group>
<article-title>Human Cardiac Organoids for Disease Modeling</article-title>
<source/>Clin. Pharmacol. Ther.
          <year>2019</year>
<volume>105</volume>
<fpage>79</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1002/cpt.1286</pub-id>
<pub-id pub-id-type="pmid">30415499</pub-id>
</element-citation>
</ref>
<ref id="B174-jpm-10-00008">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voges</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Parton</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Porrello</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Development of a human cardiac organoid injury model reveals innate regenerative potential</article-title>
<source/>Development
          <year>2017</year>
<volume>144</volume>
<fpage>1118</fpage>
<lpage>1127</lpage>
<pub-id pub-id-type="doi">10.1242/dev.143966</pub-id>
<pub-id pub-id-type="pmid">28174241</pub-id>
</element-citation>
</ref>
<ref id="B175-jpm-10-00008">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nugraha</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Buono</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Emmert</surname>
<given-names>M.Y.</given-names>
</name>
</person-group>
<article-title>Modelling human cardiac diseases with 3D organoid</article-title>
<source/>Eur. Heart J.
          <year>2018</year>
<volume>39</volume>
<fpage>4234</fpage>
<lpage>4237</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehy765</pub-id>
<pub-id pub-id-type="pmid">30576473</pub-id>
</element-citation>
</ref>
<ref id="B176-jpm-10-00008">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dekkers</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Wiegerinck</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>De Jonge</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Bronsveld</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Janssens</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>De Winter-De Groot</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Brandsma</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>De Jong</surname>
<given-names>N.W.M.</given-names>
</name>
<name>
<surname>Bijvelds</surname>
<given-names>M.J.C.</given-names>
</name>
<name>
<surname>Scholte</surname>
<given-names>B.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A functional CFTR assay using primary cystic fibrosis intestinal organoids</article-title>
<source/>Nat. Med.
          <year>2013</year>
<volume>19</volume>
<fpage>939</fpage>
<lpage>945</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3201</pub-id>
<pub-id pub-id-type="pmid">23727931</pub-id>
</element-citation>
</ref>
<ref id="B177-jpm-10-00008">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ettayebi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Broughman</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Karandikar</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Tenge</surname>
<given-names>V.R.</given-names>
</name>
<name>
<surname>Neill</surname>
<given-names>F.H.</given-names>
</name>
<name>
<surname>Blutt</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Replication of human noroviruses in stem cell-derived human enteroids</article-title>
<source/>Science
          <year>2016</year>
<volume>353</volume>
<fpage>1387</fpage>
<lpage>1393</lpage>
<pub-id pub-id-type="doi">10.1126/science.aaf5211</pub-id>
<pub-id pub-id-type="pmid">27562956</pub-id>
</element-citation>
</ref>
<ref id="B178-jpm-10-00008">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxena</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Blutt</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Ettayebi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X.-L.</given-names>
</name>
<name>
<surname>Broughman</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Karandikar</surname>
<given-names>U.C.</given-names>
</name>
<name>
<surname>Sastri</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Conner</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Opekun</surname>
<given-names>A.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human Intestinal Enteroids: A New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology</article-title>
<source/>J. Virol.
          <year>2016</year>
<volume>90</volume>
<fpage>43</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.01930-15</pub-id>
<pub-id pub-id-type="pmid">26446608</pub-id>
</element-citation>
</ref>
<ref id="B179-jpm-10-00008">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Iakobachvili</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Artegiani</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sachs</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Boonekamp</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Bowden</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hendrickx</surname>
<given-names>A.P.A.</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>R.J.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modelling Cryptosporidium infection in human small intestinal and lung organoids</article-title>
<source/>Nat. Microbiol.
          <year>2018</year>
<volume>3</volume>
<fpage>814</fpage>
<lpage>823</lpage>
<pub-id pub-id-type="doi">10.1038/s41564-018-0177-8</pub-id>
<pub-id pub-id-type="pmid">29946163</pub-id>
</element-citation>
</ref>
<ref id="B180-jpm-10-00008">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H.H.N.</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>V.K.M.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>B.H.Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus</article-title>
<source/>Sci. Adv.
          <year>2017</year>
<volume>3</volume>
<fpage>eaao4966</fpage>
<pub-id pub-id-type="doi">10.1126/sciadv.aao4966</pub-id>
<pub-id pub-id-type="pmid">29152574</pub-id>
</element-citation>
</ref>
<ref id="B181-jpm-10-00008">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forbes</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Howden</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Lawlor</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Phipson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maksimovic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hale</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Quinlan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Holman</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms</article-title>
<source/>Am. J. Hum. Genet.
          <year>2018</year>
<volume>102</volume>
<fpage>816</fpage>
<lpage>831</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2018.03.014</pub-id>
<pub-id pub-id-type="pmid">29706353</pub-id>
</element-citation>
</ref>
<ref id="B182-jpm-10-00008">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gehart</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Van Boxtel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hamer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Blokzijl</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Verstegen</surname>
<given-names>M.M.A.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Van Wenum</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>De Ligt</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-term culture of genome-stable bipotent stem cells from adult human liver</article-title>
<source/>Cell
          <year>2015</year>
<volume>160</volume>
<fpage>299</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.11.050</pub-id>
<pub-id pub-id-type="pmid">25533785</pub-id>
</element-citation>
</ref>
<ref id="B183-jpm-10-00008">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Broutier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mastrogiovanni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Verstegen</surname>
<given-names>M.M.A.</given-names>
</name>
<name>
<surname>Francies</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Gavarró</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Bradshaw</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Arnes-Benito</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sidorova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gaspersz</surname>
<given-names>M.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human primary liver cancer-derived organoid cultures for disease modeling and drug screening</article-title>
<source/>Nat. Med.
          <year>2017</year>
<volume>23</volume>
<fpage>1424</fpage>
<lpage>1435</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4438</pub-id>
<pub-id pub-id-type="pmid">29131160</pub-id>
</element-citation>
</ref>
<ref id="B184-jpm-10-00008">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nie</surname>
<given-names>Y.Z.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Sekine</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ueno</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takebe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wakita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ryo</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells</article-title>
<source/>EBioMedicine
          <year>2018</year>
<volume>35</volume>
<fpage>114</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="doi">10.1016/j.ebiom.2018.08.014</pub-id>
<pub-id pub-id-type="pmid">30120080</pub-id>
</element-citation>
</ref>
<ref id="B185-jpm-10-00008">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hakim</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response</article-title>
<source/>Hepatology
          <year>2018</year>
<volume>67</volume>
<fpage>2096</fpage>
<lpage>2112</lpage>
<pub-id pub-id-type="doi">10.1002/hep.29702</pub-id>
<pub-id pub-id-type="pmid">29194722</pub-id>
</element-citation>
</ref>
<ref id="B186-jpm-10-00008">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachs</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Papaspyropoulos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zomer-van Ommen</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Heo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Böttinger</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Klay</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Weeber</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Huelsz-Prince</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Iakobachvili</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Amatngalim</surname>
<given-names>G.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-term expanding human airway organoids for disease modeling</article-title>
<source/>EMBO J.
          <year>2019</year>
<volume>38</volume>
<fpage>e100300</fpage>
<pub-id pub-id-type="doi">10.15252/embj.2018100300</pub-id>
<pub-id pub-id-type="pmid">30643021</pub-id>
</element-citation>
</ref>
<ref id="B187-jpm-10-00008">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sachs</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>B.H.Y.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>V.K.M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differentiated human airway organoids to assess infectivity of emerging influenza virus</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>6822</fpage>
<lpage>6827</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1806308115</pub-id>
<pub-id pub-id-type="pmid">29891677</pub-id>
</element-citation>
</ref>
<ref id="B188-jpm-10-00008">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.X.</given-names>
</name>
<name>
<surname>De Carvalho</surname>
<given-names>A.L.R.T.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Volpi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Notarangelo</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Ciancanelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Casanova</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A three-dimensional model of human lung development and disease from pluripotent stem cells</article-title>
<source/>Nat. Cell Biol.
          <year>2017</year>
<volume>19</volume>
<fpage>542</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="doi">10.1038/ncb3510</pub-id>
<pub-id pub-id-type="pmid">28436965</pub-id>
</element-citation>
</ref>
<ref id="B189-jpm-10-00008">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boj</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>C.I.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Chio</surname>
<given-names>I.I.C.</given-names>
</name>
<name>
<surname>Engle</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Corbo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Jager</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ponz-Sarvise</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tiriac</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>M.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Organoid models of human and mouse ductal pancreatic cancer</article-title>
<source/>Cell
          <year>2015</year>
<volume>160</volume>
<fpage>324</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.12.021</pub-id>
<pub-id pub-id-type="pmid">25557080</pub-id>
</element-citation>
</ref>
<ref id="B190-jpm-10-00008">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shimokawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tamagawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Toshimitsu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ohta</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nanki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression</article-title>
<source/>Cell Stem Cell
          <year>2018</year>
<volume>22</volume>
<fpage>454</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2017.12.009</pub-id>
<pub-id pub-id-type="pmid">29337182</pub-id>
</element-citation>
</ref>
<ref id="B191-jpm-10-00008">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiriac</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bucobo</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Tzimas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Grewel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lacomb</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Rowehl</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Nagula</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sasson</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment</article-title>
<source/>Gastrointest. Endosc.
          <year>2018</year>
<volume>87</volume>
<fpage>1474</fpage>
<lpage>1480</lpage>
<pub-id pub-id-type="doi">10.1016/j.gie.2017.12.032</pub-id>
<pub-id pub-id-type="pmid">29325707</pub-id>
</element-citation>
</ref>
<ref id="B192-jpm-10-00008">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vela</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sboner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iaquinta</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Karthaus</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Gopalan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dowling</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wanjala</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Undvall</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>V.K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Organoid cultures derived from patients with advanced prostate cancer</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<fpage>176</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.08.016</pub-id>
<pub-id pub-id-type="pmid">25201530</pub-id>
</element-citation>
</ref>
<ref id="B193-jpm-10-00008">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parfitt</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ramsden</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>A.J.F.</given-names>
</name>
<name>
<surname>Munro</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Jovanovic</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kanuga</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Muthiah</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Hull</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification and Correction of Mechanisms Underlying Inherited Blindness in Human iPSC-Derived Optic Cups</article-title>
<source/>Cell Stem Cell
          <year>2016</year>
<volume>18</volume>
<fpage>769</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2016.03.021</pub-id>
<pub-id pub-id-type="pmid">27151457</pub-id>
</element-citation>
</ref>
<ref id="B194-jpm-10-00008">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>H.H.N.</given-names>
</name>
<name>
<surname>Siu</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>S.S.K.</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>W.Y.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>K.O.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening</article-title>
<source/>Cell Stem Cell
          <year>2018</year>
<volume>23</volume>
<fpage>882</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2018.09.016</pub-id>
<pub-id pub-id-type="pmid">30344100</pub-id>
</element-citation>
</ref>
<ref id="B195-jpm-10-00008">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seidlitz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Merker</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Rothe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zakrzewski</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Von Neubeck</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Grützmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Schweitzer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schölch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Uhlemann</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human gastric cancer modelling using organoids</article-title>
<source/>Gut
          <year>2019</year>
<volume>68</volume>
<fpage>207</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2017-314549</pub-id>
<pub-id pub-id-type="pmid">29703791</pub-id>
</element-citation>
</ref>
<ref id="B196-jpm-10-00008">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartfeld</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bayram</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Van De Wetering</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Begthel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kujala</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vries</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Clevers</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection</article-title>
<source/>Gastroenterology
          <year>2015</year>
<volume>148</volume>
<fpage>126</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2014.09.042</pub-id>
<pub-id pub-id-type="pmid">25307862</pub-id>
</element-citation>
</ref>
<ref id="B197-jpm-10-00008">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCracken</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Catá</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Sinagoga</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rockich</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Mayhew</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Spence</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Zavros</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modelling human development and disease in pluripotent stem-cell-derived gastric organoids</article-title>
<source/>Nature
          <year>2014</year>
<volume>516</volume>
<fpage>400</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="doi">10.1038/nature13863</pub-id>
<pub-id pub-id-type="pmid">25363776</pub-id>
</element-citation>
</ref>
<ref id="B198-jpm-10-00008">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonnen</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Merten</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Microfluidics as an Emerging Precision Tool in Developmental Biology</article-title>
<source/>Dev. Cell
          <year>2019</year>
<volume>48</volume>
<fpage>293</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1016/j.devcel.2019.01.015</pub-id>
<pub-id pub-id-type="pmid">30753835</pub-id>
</element-citation>
</ref>
<ref id="B199-jpm-10-00008">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingber</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Developmentally inspired human ‘organs on chips’</article-title>
<source/>Development
          <year>2018</year>
<volume>145</volume>
<fpage>dev156125</fpage>
<pub-id pub-id-type="doi">10.1242/dev.156125</pub-id>
<pub-id pub-id-type="pmid">29776965</pub-id>
</element-citation>
</ref>
<ref id="B200-jpm-10-00008">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Low</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Tagle</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Organs-on-chips: Progress, challenges, and future directions</article-title>
<source/>Exp. Biol. Med.
          <year>2017</year>
<volume>242</volume>
<fpage>1573</fpage>
<lpage>1578</lpage>
<pub-id pub-id-type="doi">10.1177/1535370217700523</pub-id>
</element-citation>
</ref>
<ref id="B201-jpm-10-00008">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gale</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jafek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Goenner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moghimifam</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nze</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Kamarapu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A Review of Current Methods in Microfluidic Device Fabrication and Future Commercialization Prospects</article-title>
<source/>Inventions
          <year>2018</year>
<volume>3</volume>
<elocation-id>60</elocation-id>
<pub-id pub-id-type="doi">10.3390/inventions3030060</pub-id>
</element-citation>
</ref>
<ref id="B202-jpm-10-00008">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sosa-Hernández</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Villalba-Rodríguez</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Romero-Castillo</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Aguilar-Aguila-Isaías</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>García-Reyes</surname>
<given-names>I.E.</given-names>
</name>
<name>
<surname>Hernández-Antonio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Parra-Saldívar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>H.M.N.</given-names>
</name>
</person-group>
<article-title>Organs-on-a-chip module: A review from the development and applications perspective</article-title>
<source/>Micromachines
          <year>2018</year>
<volume>9</volume>
<elocation-id>536</elocation-id>
<pub-id pub-id-type="doi">10.3390/mi9100536</pub-id>
<pub-id pub-id-type="pmid">30424469</pub-id>
</element-citation>
</ref>
<ref id="B203-jpm-10-00008">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Den Berg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mummery</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Passier</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Van der Meer</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>Personalised organs-on-chips: Functional testing for precision medicine</article-title>
<source/>Lab Chip
          <year>2019</year>
<volume>19</volume>
<fpage>198</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1039/C8LC00827B</pub-id>
<pub-id pub-id-type="pmid">30506070</pub-id>
</element-citation>
</ref>
<ref id="B204-jpm-10-00008">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Codreanu</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sherrod</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Markov</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Neely</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Britt</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Hoilett</surname>
<given-names>O.S.</given-names>
</name>
<name>
<surname>Reiserer</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Samson</surname>
<given-names>P.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit</article-title>
<source/>J. Neuroinflamm.
          <year>2016</year>
<volume>13</volume>
<fpage>306</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-016-0760-y</pub-id>
<pub-id pub-id-type="pmid">27955696</pub-id>
</element-citation>
</ref>
<ref id="B205-jpm-10-00008">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing</article-title>
<source/>Lab Chip
          <year>2018</year>
<volume>18</volume>
<fpage>486</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="doi">10.1039/C7LC01224A</pub-id>
<pub-id pub-id-type="pmid">29309077</pub-id>
</element-citation>
</ref>
<ref id="B206-jpm-10-00008">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wennberg Huldt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kanebratt</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Durieux</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gunne</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ewart</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Maschmeyer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-14815-w</pub-id>
<pub-id pub-id-type="pmid">28127051</pub-id>
</element-citation>
</ref>
<ref id="B207-jpm-10-00008">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coppeta</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Mescher</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Isenberg</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Lever</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Mulhern</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Prantil-Baun</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Comolli</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Borenstein</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>A portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow control</article-title>
<source/>Lab Chip
          <year>2017</year>
<volume>17</volume>
<fpage>134</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1039/C6LC01236A</pub-id>
</element-citation>
</ref>
<ref id="B208-jpm-10-00008">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Georgescu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Organoids-on-a-chip</article-title>
<source/>Science
          <year>2019</year>
<volume>364</volume>
<fpage>960</fpage>
<lpage>965</lpage>
<pub-id pub-id-type="doi">10.1126/science.aaw7894</pub-id>
<pub-id pub-id-type="pmid">31171693</pub-id>
</element-citation>
</ref>
<ref id="B209-jpm-10-00008">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wetzel</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Marriott</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dréau</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>D’Avanzo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Tanzi</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease</article-title>
<source/>Nat. Neurosci.
          <year>2018</year>
<volume>21</volume>
<fpage>941</fpage>
<lpage>951</lpage>
<pub-id pub-id-type="doi">10.1038/s41593-018-0175-4</pub-id>
<pub-id pub-id-type="pmid">29950669</pub-id>
</element-citation>
</ref>
<ref id="B210-jpm-10-00008">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herland</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>FitzGerald</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>T.-E.</given-names>
</name>
<name>
<surname>Sleeboom</surname>
<given-names>J.J.F.</given-names>
</name>
<name>
<surname>Ingber</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<elocation-id>e0150360</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0150360</pub-id>
<pub-id pub-id-type="pmid">26930059</pub-id>
</element-citation>
</ref>
<ref id="B211-jpm-10-00008">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Akay</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Akay</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Engineering a Brain Cancer Chip for High-throughput Drug Screening</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>25062</fpage>
<pub-id pub-id-type="doi">10.1038/srep25062</pub-id>
<pub-id pub-id-type="pmid">27151082</pub-id>
</element-citation>
</ref>
<ref id="B212-jpm-10-00008">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Helm</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Eijkel</surname>
<given-names>J.C.T.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Segerink</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Microfluidic organ-on-chip technology for blood-brain barrier research</article-title>
<source/>Tissue Barriers
          <year>2016</year>
<volume>4</volume>
<fpage>e1142493</fpage>
<pub-id pub-id-type="doi">10.1080/21688370.2016.1142493</pub-id>
<pub-id pub-id-type="pmid">27141422</pub-id>
</element-citation>
</ref>
<ref id="B213-jpm-10-00008">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McCain</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pasqualini</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zangi</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies</article-title>
<source/>Nat. Med.
          <year>2014</year>
<volume>20</volume>
<fpage>616</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3545</pub-id>
<pub-id pub-id-type="pmid">24813252</pub-id>
</element-citation>
</ref>
<ref id="B214-jpm-10-00008">
<label>214.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Ugolini</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Visone</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cruz-Moreira</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mainardi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rasponi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Generation of functional cardiac microtissues in a beating heart-on-a-chip</article-title>
<source/>Methods in Cell Biology
          <publisher-name>Academic Press Inc.</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2018</year>
<fpage>69</fpage>
<lpage>84</lpage>
<isbn>9780128142806</isbn>
</element-citation>
</ref>
<ref id="B215-jpm-10-00008">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunes</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Feric</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pahnke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miklas</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Coles</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gagliardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Radisic</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure</article-title>
<source/>ACS Biomater. Sci. Eng.
          <year>2017</year>
<volume>3</volume>
<fpage>1911</fpage>
<lpage>1921</lpage>
<pub-id pub-id-type="doi">10.1021/acsbiomaterials.5b00496</pub-id>
</element-citation>
</ref>
<ref id="B216-jpm-10-00008">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Lidberg</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bammler</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Redhair</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Atkins</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hines</surname>
<given-names>K.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity</article-title>
<source/>JCI Insight
          <year>2018</year>
<volume>3</volume>
<fpage>123673</fpage>
<pub-id pub-id-type="doi">10.1172/jci.insight.123673</pub-id>
<pub-id pub-id-type="pmid">30568031</pub-id>
</element-citation>
</ref>
<ref id="B217-jpm-10-00008">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortega-Prieto</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Skelton</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Wai</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Large</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lussignol</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vizcay-Barrena</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fleck</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Thursz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Catanese</surname>
<given-names>M.T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-02969-8</pub-id>
<pub-id pub-id-type="pmid">29317637</pub-id>
</element-citation>
</ref>
<ref id="B218-jpm-10-00008">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>George</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Vernetti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gough</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX</article-title>
<source/>Lab Chip
          <year>2018</year>
<volume>18</volume>
<fpage>2614</fpage>
<lpage>2631</lpage>
<pub-id pub-id-type="doi">10.1039/C8LC00418H</pub-id>
<pub-id pub-id-type="pmid">30063238</pub-id>
</element-citation>
</ref>
<ref id="B219-jpm-10-00008">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction</article-title>
<source/>Biomicrofluidics
          <year>2019</year>
<volume>13</volume>
<fpage>024101</fpage>
<pub-id pub-id-type="doi">10.1063/1.5070088</pub-id>
<pub-id pub-id-type="pmid">31040885</pub-id>
</element-citation>
</ref>
<ref id="B220-jpm-10-00008">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Simonelli</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Giannitelli</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Businaro</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Trombetta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rainer</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Investigating nonalcoholic fatty liver disease in a liver-on-a-chip microfluidic device</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<elocation-id>e0159729</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0159729</pub-id>
<pub-id pub-id-type="pmid">27438262</pub-id>
</element-citation>
</ref>
<ref id="B221-jpm-10-00008">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Engineered liver-on-a-chip platform to mimic liver functions and its biomedical applications: A review</article-title>
<source/>Micromachines
          <year>2019</year>
<volume>10</volume>
<elocation-id>676</elocation-id>
<pub-id pub-id-type="doi">10.3390/mi10100676</pub-id>
<pub-id pub-id-type="pmid">31591365</pub-id>
</element-citation>
</ref>
<ref id="B222-jpm-10-00008">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Punde</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Lien</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M.D.T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>Y.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A biologically inspired lung-on-a-chip device for the study of protein-induced lung inflammation</article-title>
<source/>Integr. Biol.
          <year>2015</year>
<volume>7</volume>
<fpage>162</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1039/c4ib00239c</pub-id>
<pub-id pub-id-type="pmid">25486073</pub-id>
</element-citation>
</ref>
<ref id="B223-jpm-10-00008">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Trueeb</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Stucki</surname>
<given-names>A.O.</given-names>
</name>
<name>
<surname>Borcard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stucki</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Schnyder</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Geiser</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Guenat</surname>
<given-names>O.T.</given-names>
</name>
</person-group>
<article-title>Impaired wound healing of alveolar lung epithelial cells in a breathing lung-on-a-chip</article-title>
<source/>Front. Bioeng. Biotechnol.
          <year>2019</year>
<volume>7</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.3389/fbioe.2019.00003</pub-id>
<pub-id pub-id-type="pmid">30746362</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="jpm-10-00008-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Schematic of ex vivo stem-cell based modeling systems. (<bold>a</bold>) Autologous stem cells from a donor heathy subject/patient, and patient-specific induced pluripotent stem cells (iPSCs) (<bold>b</bold>), may be source for generating: (<bold>c</bold>) Committed/differentiated cells; (<bold>d</bold>) 3D-biohybrid system; (<bold>e</bold>) organoids; and (<bold>f</bold>) organ-on-a-chip. The presence of computer icons indicates the critical role of the computational tools on the model design and the data elaboration. <inline-graphic xlink:href="jpm-10-00008-i001.jpg"></inline-graphic>, indicates the application of gene therapy and/or CRISPR/Cas9 to each system.</p>
</caption>
<graphic xlink:href="jpm-10-00008-g001"></graphic>
</fig>
<table-wrap id="jpm-10-00008-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">jpm-10-00008-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>List of modeler environments software.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Software</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Application</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Link</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">BIOCHAM4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A software environment for modeling biochemical systems</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://lifeware.inria.fr/biocham4/">https://lifeware.inria.fr/biocham4/</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B22-jpm-10-00008">22</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bio-SPICE</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Biological simulation software for intra- and inter-cellular evaluation, modeling and simulation of spatio-temporal processes in living cells</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="http://biospice.sourceforge.net">http://biospice.sourceforge.net</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B23-jpm-10-00008">23</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CellML</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CellML allows scientists to store and share computer-based mathematical models</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://www.cellml.org">https://www.cellml.org</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B24-jpm-10-00008">24</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">COPASI: Biochemical System Simulator</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A software application for simulation and analysis of biochemical networks and their dynamics</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="http://copasi.org">http://copasi.org</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B25-jpm-10-00008">25</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E-Cell System</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A software platform for modeling, simulation and analysis of complex, heterogeneous and multi-scale systems like the cell</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="http://www.e-cell.org">http://www.e-cell.org</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B26-jpm-10-00008">26</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">EPISIM</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A platform for graphical multi-scale modeling and simulation of multicellular systems</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="http://tigacenter.bioquant.uni-heidelberg.de/episim.html">http://tigacenter.bioquant.uni-heidelberg.de/episim.html</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B27-jpm-10-00008">27</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MCell</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A program that uses spatially realistic 3D cellular models and specialized Monte Carlo algorithms to simulate the movements and reactions of molecules within and between cells</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="http://www.mcell.psc.edu">http://www.mcell.psc.edu</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B28-jpm-10-00008">28</xref>,<xref ref-type="bibr" rid="B29-jpm-10-00008">29</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Morpheus</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A modeling and simulation environment for the study of multi-scale and multicellular systems</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://morpheus.gitlab.io">https://morpheus.gitlab.io</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B30-jpm-10-00008">30</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tissue Simulation Toolkit</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A two-dimensional library for the Cellular Potts Model to study tissue patterning and developmental mechanisms</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://biomodel.project.cwi.nl/software/software#TST">https://biomodel.project.cwi.nl/software/software#TST</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B31-jpm-10-00008">31</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">VCell</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A general computational framework for modeling physicochemical and electrophysiological processes in living cells and for treating spatially resolved models</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://vcell.org">https://vcell.org</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B32-jpm-10-00008">32</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="jpm-10-00008-t003" orientation="portrait" position="float">
<object-id pub-id-type="pii">jpm-10-00008-t003_Table 3</object-id>
<label>Table 3</label>
<caption>
<p>List of on-line tools for guide RNA (gRNA) design.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Software</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Link</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CasFinder</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="http://arep.med.harvard.edu/CasFinder/">http://arep.med.harvard.edu/CasFinder/</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B107-jpm-10-00008">107</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CHOP-CHOP</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://bitbucket.org/valenlab/chopchop/src/master/">https://bitbucket.org/valenlab/chopchop/src/master/</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B108-jpm-10-00008">108</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CRISPR-ERA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="http://crispr-era.stanford.edu/">http://crispr-era.stanford.edu/</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B109-jpm-10-00008">109</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CRISPR-DO</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://bitbucket.org/jianma/crisprdo/src/default/">https://bitbucket.org/jianma/crisprdo/src/default/</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B110-jpm-10-00008">110</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GuideScan</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://bitbucket.org/arp2012/guidescan_public/src/master/">https://bitbucket.org/arp2012/guidescan_public/src/master/</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B111-jpm-10-00008">111</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">mm10db</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<uri xlink:href="https://github.com/bmds-lab/mm10db/">https://github.com/bmds-lab/mm10db/</uri>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B112-jpm-10-00008">112</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="jpm-10-00008-t004" orientation="portrait" position="float">
<object-id pub-id-type="pii">jpm-10-00008-t004_Table 4</object-id>
<label>Table 4</label>
<caption>
<p>List of tissue engineering therapeutic approaches used in clinic.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Product</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Pathology</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Approval</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Company</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ChondroCelect</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cartilage diseases</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">European Medicines Agency (EMA) (2009, now withdrawn)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TiGenix.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B126-jpm-10-00008">126</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dermagraft</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diabetic foot ulcer and venous leg ulcer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">USA FDA (2010)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Organogenesis inc.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B127-jpm-10-00008">127</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Epicel</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Deep dermal or full-thickness burns</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">USA FDA (2016)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vericel Corporation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B129-jpm-10-00008">129</xref>,<xref ref-type="bibr" rid="B130-jpm-10-00008">130</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Holoclar</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Limbal stem cell deficiency</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">EMA (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Chiesi Farmaceutici S.p.A.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B131-jpm-10-00008">131</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maci</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Knee cartilage lesions</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">USA FDA (2016)<break></break>EMA (2013, now withdrawn)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vericel Denmark ApS</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B132-jpm-10-00008">132</xref>,<xref ref-type="bibr" rid="B133-jpm-10-00008">133</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Spherox</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cartilage defects in knee joints</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">EMA (2017)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Codon AG</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B134-jpm-10-00008">134</xref>] </td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="jpm-10-00008-t005" orientation="portrait" position="float">
<object-id pub-id-type="pii">jpm-10-00008-t005_Table 5</object-id>
<label>Table 5</label>
<caption>
<p>List of human organoids disease models.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Organ</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Disease</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Model Derivation</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Ref.</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bladder</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bladder cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B150-jpm-10-00008">150</xref>,<xref ref-type="bibr" rid="B151-jpm-10-00008">151</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Blood vessel</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diabetic vasculopathy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial iPSCs and patient-derived endothelial cells</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B152-jpm-10-00008">152</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="8" style="border-bottom:solid thin" valign="middle">Brain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Microcephaly</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial ESCs and commercial iPSCs.</td>
<td align="center" colspan="1" rowspan="8" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B153-jpm-10-00008">153</xref>,<xref ref-type="bibr" rid="B154-jpm-10-00008">154</xref>,<xref ref-type="bibr" rid="B155-jpm-10-00008">155</xref>,<xref ref-type="bibr" rid="B156-jpm-10-00008">156</xref>,<xref ref-type="bibr" rid="B157-jpm-10-00008">157</xref>,<xref ref-type="bibr" rid="B158-jpm-10-00008">158</xref>,<xref ref-type="bibr" rid="B159-jpm-10-00008">159</xref>,<xref ref-type="bibr" rid="B160-jpm-10-00008">160</xref>,<xref ref-type="bibr" rid="B161-jpm-10-00008">161</xref>,<xref ref-type="bibr" rid="B162-jpm-10-00008">162</xref>,<xref ref-type="bibr" rid="B163-jpm-10-00008">163</xref>,<xref ref-type="bibr" rid="B164-jpm-10-00008">164</xref>,<xref ref-type="bibr" rid="B165-jpm-10-00008">165</xref>,<xref ref-type="bibr" rid="B166-jpm-10-00008">166</xref>,<xref ref-type="bibr" rid="B167-jpm-10-00008">167</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Autism spectrum disorder (ASD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">iPSCs derived from idiopathic ASD families</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Miller-Dieker syndrome (lissencephaly)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived iPSCs</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Glioblastoma</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neonatal microcephaly due to Zika virus infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">hiPSCs and human embryonic stem cells (hESCs)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived iPSCs</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Familial Alzheimer’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived iPSCs</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parkinson’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived iPSCs</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Breast</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Breast cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B168-jpm-10-00008">168</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Colon</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B169-jpm-10-00008">169</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Endometrium</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endometriosis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B170-jpm-10-00008">170</xref>,<xref ref-type="bibr" rid="B171-jpm-10-00008">171</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endometrial cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lynch syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Esophagus</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Esophageal Adenocarcinoma</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B172-jpm-10-00008">172</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Heart</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Local Injury</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Commercial hESCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B173-jpm-10-00008">173</xref>,<xref ref-type="bibr" rid="B174-jpm-10-00008">174</xref>,<xref ref-type="bibr" rid="B175-jpm-10-00008">175</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="5" style="border-bottom:solid thin" valign="middle">Intestine</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cystic fibrosis (CF)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intestinal biopsies and crypt isolation</td>
<td align="center" colspan="1" rowspan="5" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B176-jpm-10-00008">176</xref>,<xref ref-type="bibr" rid="B177-jpm-10-00008">177</xref>,<xref ref-type="bibr" rid="B178-jpm-10-00008">178</xref>,<xref ref-type="bibr" rid="B179-jpm-10-00008">179</xref>,<xref ref-type="bibr" rid="B180-jpm-10-00008">180</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Acute gastroenteritis due to human Noroviruse infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Healthy donors’ intestinal biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diarrheal illness due to human Rotavirus infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Healthy donors’ duodenal and ileal biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diarrheal illness due to <italic>Cryptosporidium</italic> infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Healthy donors’ duodenal biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Respiratory infection due to Middle East respiratory syndrome coronavirus</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Healthy donors’ colon biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kidney</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Nephronophthisis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B181-jpm-10-00008">181</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">LIVER</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">α1-antitrypsin deficiency</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Liver biopsies</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B182-jpm-10-00008">182</xref>,<xref ref-type="bibr" rid="B183-jpm-10-00008">183</xref>,<xref ref-type="bibr" rid="B184-jpm-10-00008">184</xref>,<xref ref-type="bibr" rid="B185-jpm-10-00008">185</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Primary liver cancers</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hepatitis B infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Healthy donor iPSCs</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hepatitis E infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Liver biopsies of patients affected</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">LUNG</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lung cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Non-small cell lung cancer biopsies</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B179-jpm-10-00008">179</xref>,<xref ref-type="bibr" rid="B186-jpm-10-00008">186</xref>,<xref ref-type="bibr" rid="B187-jpm-10-00008">187</xref>,<xref ref-type="bibr" rid="B188-jpm-10-00008">188</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diarrheal illness due to <italic>Cryptosporidium</italic> infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Non-small cell lung cancer biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Influenza virus infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Healthy donor’s lung biopsies</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lung bronchiolitis and fibrosis due to respiratory syncytial virus infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">hPSCs</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PANCREAS</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pancreatic ductal adenocarcinoma</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B189-jpm-10-00008">189</xref>,<xref ref-type="bibr" rid="B190-jpm-10-00008">190</xref>,<xref ref-type="bibr" rid="B191-jpm-10-00008">191</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PROSTATE</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prostate cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients metastasis samples</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B192-jpm-10-00008">192</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RETINA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Leber congenital amaurosis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient-derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B193-jpm-10-00008">193</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">STOMACH</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gastric cancer</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patients tumor biopsies</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B194-jpm-10-00008">194</xref>,<xref ref-type="bibr" rid="B195-jpm-10-00008">195</xref>,<xref ref-type="bibr" rid="B196-jpm-10-00008">196</xref>,<xref ref-type="bibr" rid="B197-jpm-10-00008">197</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gastric diseases due to <italic>Helicobacter pylori</italic> infection</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gastric/esophageal tumor biopsies or commercial PSCs</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>